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Abstract
The psychological impact of chronic liver disease is vast, including the
psychiatric and psychosocial consequences of chronic illness, and the
cognitive deficits experienced due to hepatic encephalopathy. Orthotopic
liver transplantation is now the treatment of choice for end-stage chronic
liver disease, and it is now recognised that psychological factors play an
important role in the evaluation of its outcome, as well as the more
traditional measures of morbidity and mortality. Successful liver
transplant recipients face a lifetime of drug regimens as well as the
common psychological difficulties associated with transplantation,
including fear of rejection and preoccupation with the donor. Preliminary
findings have suggested that liver transplant recipients experience
enhanced quality of life post-operatively compared to pre-transplant
levels, although not at the level experienced by the general population.
Investigation of the neuropsychological functioning of recipients has also
produced mixed, although generally positive results. Much of the
research in this field has, however, been methodologically flawed with the
use of non-standardised measures, lack of control groups and
retrospective, cross-sectional designs. Using a prospective design the
present study aimed to investigate the effects of liver transplantation on
neuropsychological functioning, psychiatric status and quality of life.
Subjects were assessed pre-transplant and approximately three years post-
transplant, as were a group of patients with liver disease not considered
for transplantation and healthy controls. The roles of social support and
self-esteem were investigated. The results were analysed and discussed.
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Liver transplantation involves major surgery, the possibility of many
postoperative complications, and a lifetime of strict anti-rejection drug
regimens. Nevertheless, it is the treatment of choice for end-stage liver
disease and there are currently around 400 liver transplants undertaken in
the United Kingdom every year, compared to less than 40 in 1981 (Price et
al. 1995). The outcome of this treatment has traditionally been evaluated
in purely medical terms. Interest in psychological factors is, however,
growing. Neuropsychological impairment associated with liver disease,
known as hepatic encephalopathy, has been well documented (e.g. Tarter
et al., 1988a; Gammal & Jones, 1989). It has also been shown that the
majority of patients suffering from chronic liver disease demonstrate
cognitive impairment, often going unrecognised by doctors, known as
latent, or sub-clinical hepatic encephalopathy (e.g. Tarter et al., 1990a;
O'Carroll et al., 1991). It is assumed that successful treatment of the
underlying liver disease would lead to a recovery of neuropsychological
functions. A number of studies have used batteries of neuropsychological
tests to investigate the outcome of liver transplantation. These studies
will be discussed and evaluated. The role of alcohol abuse in this
literature shall be discussed. Another major area of research in the field of
liver transplantation is its outcome in terms of the quality of life of
recipients, and an evaluation of the literature assessing quality of life shall
be carried out. Adjustment to chronic illness can be a difficult process,
involving the loss of roles and enjoyment of activities. Successful liver
transplantation can restore many of these losses. Major surgery, and
resulting complications and scarring have also been associated with
adjustment difficulties. These issues will be discussed. The relationship
between social support and health is complex, but adequate social support
has been reported to be associated with good adjustment to illness, as well
as a better health outcome. The role of social support shall be discussed,
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although no studies have assessed this variable in the field of liver
transplant research. Finally, the concept of self-esteem and its
relationship to health shall be discussed. The aims of the present study
will then be outlined.
1.2. The Liver
The liver plays an integral role in sustaining the nutritional and metabolic
well-being of an individual: it determines whether to store or use
immediately absorbed nutrients; it stores and activates several vitamins; it
is involved in protein synthesis; it regulates the plasma level of
cholesterol and other fats; it removes large cellular and protein foreign
material from the circulation; and it manufactures bile. The obstruction of
blood flow within the liver (portal venous obstruction) due to either
cholestatic (obstruction of bile flow), or hepatocellular disease, results in
hypertension and the shunting of portal venous blood around rather than
through the liver. Thus the liver is no longer able to filter and metabolise
portal venous blood constituents, and of particular interest to
neuropsychologists, putative cerebrotoxins are not degraded and enter the
systemic blood flow. This portal-systemic shunting of blood (which is also
surgically induced to reduce hypertension) is the main cause of the
complex neuropsychiatric syndrome known as hepatic encephalopathy
(HE, Crossley & Williams, 1984).
1.3. Hepatic Encephalopathy
No strict definition of HE exists, although it is generally described as a
potentially reversible metabolic encephalopathy, with augmented neural
inhibition (Gammal & Jones, 1989). HE is usually categorised according to
a rating scale devised by Parsons-Smith et al. (1957), which is a five point
scale from 0 (no abnormality detected) to IV (coma). The earliest signs
include psychiatric and behavioural changes and subtle changes in
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intellectual function. Then motor function, intellectual abilities and
consciousness become noticeably impaired, followed by coma. It has
recently been discovered that the crude nature of this rating scale has
masked subtle deficits. Many patients suffering from liver disease, who
have no evidence of HE upon clinical examination, have significant
neuropsychological deficits. This impairment, known as latent HE (LHE),
or subclinical HE, is evident from neuropsychological testing (Conn &
Lieberthal, 1978; Gilberstadt et al., 1980; Tarter et al., 1984). Macroscopic
abnormalities of cerebral morphology have been demonstrated by CT scan
abnormalities (Bernthal et al., 1987; Tarter et al., 1986a), NMR imaging
(Moore et al., 1989). Finally, abnormal event-related potentials have been
reported in cirrhotics without overt signs of HE (Kugler et al., 1992; Yang &
Chu, 1985). It is generally agreed, however, that LHE is most sensitively
assessed by means of neuropsychological testing (Tarter et al., 1989; Conn
& Lieberthal, 1978; McClain, 1980). Furthermore, EEG investigations are
normal in 66-94% of patients with LHE, and if abnormalities are detected
on an EEG, more severe abnormalities are evident on neuropsychological
testing (Rikkers et al., 1978; Schomerus et al., 1981; Gitlin et al., 1986; Dunk
et al., 1988). There are a number of candidates for toxic factors that may be
responsible for HE: ammonia; fatty acids; mercaptans; aminobutyric acid;
plasma amino acid imbalance (Zeive, 1981; Schafer & Jones, 1982; Fischer
& Baldessarini, 1971; James et al., 1979). No single hypothesis, however,
accounts successfully for the development of HE in all patients (Lockwood,
1987).
1.3.1. Neuropsychological Investigation
There is now a growing body of literature examining the
neuropsychological sequelae of liver disease, and the use of extensive
batteries of standardised assessment tools has enabled fairly good
replication and comparison of findings. Comparing 19 non-alcoholic
cirrhotics, with controls matched on age, sex and education, Moore et al.,
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(1989) used the Benton Visual Retention Test, Trails A & B and reaction
times to light, sound and choice stimuli. They found that 84% of the
cirrhotic group failed two or more tests whereas none of the control
subjects failed any tests. Generally, performance skills are impaired while
verbal skills remain fairly intact (Moore et al., 1992). In particular,
visuospatial, psychomotor and memory impairments have been reported
in cirrhotics who are not overtly encephalopathic (Tarter et al., 1987a;
Tarter et al., 1984; Hegedus et al., 1984; Giberstadt et al., 1980). The
number connection test (Trails A, TMT A) has been reported to be
particularly good at identifying LHE and its routine application has been
recommended (Gammal & Jones, 1989). A number of studies have,
however, found it to be one of the poorest indicators of impairment
associated with LHE (O'Carroll et al., 1991; Moore et al., 1989). Many
studies have found the digit symbol substitution and digit span subtests of
the WAIS-R to be sensitive indicators of LHE (O'Carroll et al., 1991; Tarter
et al., 1990a; Elsass et al., 1978; Schomerus et al., 1981; Gitlin et al., 1986;
Dunk et al., 1988). Nevertheless, there is still no widespread agreement
about which measures should be used, and it has been noted that many
factors influence the nature and the extent of neuropsychological
impairment in each person with liver disease (Tarter et al., 1988a). Some
studies have attempted to evaluate treatment approaches to HE & LHE
using neuropsychological test performance indicators (McClain et al., 1984;
Egberts et al., 1985). Other studies have attempted to correlate
neuropsychological test performance with biochemical measures
associated with liver disease, therefore making early diagnosis of LHE
easier. For example, Tarter et al. (1989) found that albumin and
prothrombin time could explain a significant amount of the variance on
neuropsychological testing in 79 non-alcoholic cirrhotics. They concluded
that measures of functional liver status were related to cognitive capacity,
even when impairment was not overtly evident.
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1.3.2. Implications of LHE
The implications of the performance deficits found in LHE are significant
and may lead to impairment of an individual's abilities to safely perform
important activities of daily living, including driving (Schomerus et al,
1981; Rikkers et al, 1978; Gitlin et al, 1986). How much LHE impairs a
patient's day-to-day functioning depends largely on the demands placed
upon him or her (Schomerus et al, 1981). Further, under-diagnosis
deprives patients with LHE of the opportunity to commence early
treatment, and there is evidence that 50% of patients with LHE will
develop HE within 6 months (Yen & Liaw, 1990).
1.3.3. The Role of Transplantation in the Investigation of LHE
Due to the reversible nature of LHE, it can be assumed that effective
treatment of the underlying liver disease would eradicate the symptoms of
LHE. The study of patients undergoing liver transplantation has provided
a unique research paradigm in which the nature of the neuropsychological
impairment can be studied, and initial results have been encouraging.
1.3.4. Neuropsychological Outcome of Orthotopic Liver Transplantation
(OLT).
The work by Tarter and colleagues in Pittsburgh has produced some of the
best controlled studies investigating the neuropsychological outcome of
OLT. They assessed ten OLT recipients, approximately 3 years post-
transplant, and compared them with 10 patients suffering from Crohn's
disease (a chronic gastro-intestinal tract disease) on an extensive battery of
tests (Tarter et al., 1984). No differences were found between the groups or
when compared to population norms. The sample of OLT recipients was
young (mean age 28 years) which may have influenced the positive
results, and no pre-transplant data were included. In a larger, controlled
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study, Tarter et al (1990a) evaluated 62 patients before, and an average of 60
weeks post liver transplantation, on a battery of neuropsychological tests.
The battery was extensive and included the following tests: language
capacity (token, animal naming, Shipley vocabulary); abstracting (Shipley
abstracting); perception (Rey-Osterriech figure copy, trailmaking, block
design, stroop); psychomotor (finger tapping, grooved pegboard, static
ataxia); memory (digit span, digit supraspan, Benton visual retention,
Brown-Peterson, dichotic numbers, Rey-Osterriech memory). They also
included two control groups in the study; 22 patients suffering from
Crohn's disease and 38 well matched healthy controls, all of whom were
evaluated on two occasions. They found that prior to transplant,
compared to healthy controls, liver disease patients were impaired on 12
out of 27 tests; those quantifying perceptual and visuospatial capacity and
short-term memory. The performance of the Crohn's disease group lay
somewhere between, and not significantly different to, that of the healthy
controls and the liver disease groups. Upon repeat testing post¬
transplantation, only 4 out of the 27 tests discriminated between the
transplanted and the healthy control groups. There was no differences
between the Crohn's disease and the healthy control groups, and on only
one test (digit symbol substitution test) were the transplanted group
impaired compared to the Crohn's disease group. The authors noted that
not all of the deficits displayed by the liver disease group prior to
transplant were distinguishable from the Crohn's disease group, which
suggested that a degree of neuropsychological impairment may accompany
any chronic illness.
Similarly, Moore et al. (1992) assessed the cognitive function of 9 liver
transplant recipients pre- and 30 days, 3 and 9 months post-transplant and
compared them with 9 matched controls. They used a very lengthy
assessment battery, the Wechsler Adult Intelligence Scale - Revised
(WAIS-R), the Wechsler Memory Scale - Revised (WMS-R), The Rey-
Osterreich figure and the Benton Controlled Aural Word Test. Liver
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transplant recipients improved on tests measuring visual-motor co¬
ordination, perceptual organisation and attention. In contrast, the control
group's performance did not change over time. No test data were
included and no statistical analysis was reported, thus limiting the
conclusions that can be drawn from this paper. A further study which
failed to report any statistical analysis assessed weuropsychological status
between 4 and 36 months post-operatively in 41 liver transplant recipients
(Wolcott et al, 1989). This sample clearly comprises a very diverse group
of patients, and no control group or pre-transplant data were available.
Neuropsychological investigation included the following measures:
controlled oral word association test; digit symbol substitution subtest
(DSST) of WAIS-R; trailmaking tests A & B; Rey adult verbal learning test
(RAVLT); number cancellation test; block design subtest of WAIS-R; and
arithmetic subtest of WAIS-R. Respondents performed poorly on the
DSST and the RAVLT. Interestingly, the authors reported that those
subjects assessed greater than 12 months post-operatively performed worse
than those assessed less than 12 months post-operatively.
Finally, a prospective study compared 11 OLT recipients with 9 heart
transplant recipients using a battery of neuropsychological tests (Reither et
al., 1992). Subjects were assessed pre-transplant, and at three monthly
intervals up to one year post-transplant. Tests used were the mini-mental
state examination (MMSE), California verbal learning test (CVLT),
Wisconsin card sorting test (WCST), and the trailmaking tests A & B.
Cognitive impairment was evidenced by the CVLT, the WCST and the
TMT A prior to transplant in both groups of patients. Significant
improvements over time post-transplant were noted for both groups in
these tests. The MMSE failed to detect any cognitive impairment and it
was concluded that it was not sensitive to the problems experienced by
these patient groups. Collis et al. (1995) also used the MMSE with a group
of liver transplant recipients and found that only one out of thirty patients
showed impairment.
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1.3.5. Conclusions: Neuropsychological Impairment Associated with LHE
In conclusion, the cognitive impairment associated with latent hepatic
encephalopathy is now well documented by the use of neuropsychological
tests, and several studies have investigated the neuropsychological
outcome of liver transplantation. A wide variety of tests have been used,
and a number have been recommended for specific use with this patient
population. There is conflicting evidence concerning the efficacy of the
Trailmaking A test, and due to the number of reports that it is insensitive
to the impairments associated with LHE, its use with this population is
not recommended. The digit symbol substitution subtest of the WAIS-R,
however, has been reported to be a good indicator of neuropsychological
dysfunction in this patient group. Further, the digit span subtest of the
WAIS-R has also been recommended for use as a working memory test,
although it also has a component measuring attention. The issue of
improvements linked to repeat testing must also be highlighted, although
it has been neglected by a number of researchers. Healthy control groups
are essential to ensure that the effects of repeat testing can be excluded
from the results reported. Further, the use of assessment tools which
have parallel measures would be beneficial in studies with prospective
designs.
1.4. The Role ofAlcohol Abuse in Hepatic Encephalopathy
There is a large body of literature describing the neuropsychological
disturbances demonstrated by alcoholics (e.g. Tarter et al., 1990b).
Psychometric tests have identified memory, visuopractic, and
psychomotor impairments in alcoholics (Wilkinson & Pavlos, 1987;
Parsons & Farr, 1981). Considerable recovery of function with prolonged
abstinence has been found, indicating that many of the cognitive deficits
are not permanent (Grant, 1987; Brandt et al., 1983). There exists, however,
considerable ambiguity regarding their aetiology. The neurotoxic effects of
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ethanol are known, although it is now clear that many other factors,
including psychiatric, genetic and medical factors, contribute to the
neuropsychological deficits (Adams & Grant, 1984.). In particular, the
effects of depression and poor liver function have been found to
contribute to the cognitive problems experienced by alcoholics (Schafer et
al., 1991). The neuropsychological deficits associated with depression
have been well identified (Gilbert, 1984; Weingartner & Siberman, 1984),
as have those associated with liver disease (see section 1.3.). Nevertheless,
the deficits due to alcohol toxicity must be taken into account when
investigating the neuropsychological outcome of liver disease and its
treatment, including transplantation. In studies comparing alcoholics
with and without cirrhosis, it has been shown that impaired liver
function, probably as a consequence of HE, adversely affects
neuropsychological capacity beyond that which can be accounted for by the
effects of alcoholism alone (Giberstadt et al., 1980; Rikkers et al., 1978;
Tarter et al., 1986a). Moore et al. (1989) used a battery of
neuropsychological assessments on a group of 9 non-alcoholic cirrhotics
(without overt signs of encephalopathy), a group of 10 alcoholic cirrhotics
(without overt signs of encephalopathy) and two groups of healthy
controls, matched to the alcoholic and non-alcoholic cirrhotics. They
found no differences between the alcoholic and the non-alcoholic groups
on any of the neuropsychological tests performed, but both performed
significantly worse than the healthy controls (see Table 1). Thus the
neuropsychological dysfunction detected in alcoholics with cirrhosis can
be accounted for by LHE alone.
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Table 1. Comparison of neuropsychological functioning of alcoholic














5.5 (1.4) 7.6 (1.9) 4.0 (2.7) 7.7 (1.7)
Benton VRT
(errors)
7.5 (3.6) 3.2 (2.2) 9.9 (6.0) 3.3 (2.6)
Trails A 37 (9) 32 (13) 52 (26) . 39 (13)
Trails B 85 (32) 81 (22) 133 (91) 106 (44)
Reaction time-
light
281 (76) 210 (31) 363 (179) 242 (34)
Reaction time-
sound
316 (101) 241 (28) 423 (193) 231 (72)
Reaction time-
choice
616 (216) 380 (116) 700 (146) 434 (78)
Similar results were reported by Rehnstrom et al. (1977), who found no
difference in neuropsychological test results between a group of non¬
alcoholic cirrhotics and a group of alcoholic cirrhotics. Both these groups
performed significantly worse than a group of alcoholics without cirrhosis,
although no healthy control group was included for comparison. Finally,
Arria et al. (1991) demonstrated improvement in cognitive functioning of
13 alcoholic cirrhotics one year following OLT, providing further evidence
that a reversible HE underlies many of the neuropsychological deficits
found in alcoholic cirrhotics pre-transplant.
In conclusion, the cognitive impairment experienced by alcoholic
cirrhotics is both multifactorial and to a degree reversible upon abstinence
and treatment for liver disease. Further, findings of similar cerebral
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dysfunction in patients with cirrhosis, with different aetiologies, including
alcohol, confirm the view that neuropsychological impairment in these
groups is due to hepatic disease rather than alcohol. The inclusion of
alcoholics in liver disease research is thus justified, and very common.
1.5. PSYCHOLOGICAL ADJUSTMENT TO CHRONIC ILLNESS
The impact that suffering from a life threatening disease has on the
mental health of an individual can be vast. The literature on
psychological aspects of physical disability provides a framework from
which to understand the experiences of a patient suffering from chronic
liver disease. There are a number of factors which may affect adjustment
to a disability, including the age of onset, chronic versus acute onset,
stability of condition and prognosis, severity of disability and degree of
disability, intellectual functioning and personality change, and the
presence of absence of pain (Wilkinson, 1995). There are three main
theories about the psychological adjustment to disability: personality-
based, social context and behavioural learning. The personality-based
theorists liken disability to the experience of loss, in that the person will
move through a series of stages or tasks in coming to terms with the
disability. These stages include shock, denial, grief, anger and then finally
adjustment. It is clear, however, that not all those who experience
disability or illness go through these stages as a necessary step to
adjustment. Further, there is no evidence of a relationship between
severity of disease and psychological disturbance, which would be expected
by a stage theory of adjustment. A second theory states that adjustment to
disability is related to social networks and control over resources available,
and therefore economic considerations are paramount (see Ben Sira, 1983
for review). Idealised images of normality, success and self-esteem being
related to body-image and material well-being fuel prejudice against
disabled people and have an impact on adjustment to disability. There is
little evidence, however, to support this theory. The behavioural learning
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theory of disability incorporates both of the above theories, stating that the
adaptation to disability is a learning process, based on principles of classical
and operant conditioning and the availability of rewards and
reinforcements (Fordyce, 1971). The individual has to replace the loss of
previously satisfying activities and goals, which depends both on the
individual's abilities and the availability within the environment of
alternative means of satisfaction. This theory certainly seems to provide a
better understanding of psychological reactions to disability, in which the
individual's behaviour and the environment within which the behaviour
occurs are equally important.
Assessment tools used to measure the psychological reaction to disability
and illness fall into three main categories, those specifically looking at the
response to illness, those aiming to measure quality of life, and those
measuring general measures of psychological distress. The present study
aims to assess the psychological reaction to chronic liver disease and liver
transplantation directly using the Acceptance of Illness Scale (AIS, Felton
et al„ 1984).
1.6. PsychologicalReactions to Surgery
The literature on the psychological reactions to surgery is incomplete and
confusing. Surgeons tend to neglect concerns about the psychological
welfare of their patients when considering the need to reduce their
waiting lists and boost their productivity figures. Nevertheless, the impact
of good psychological adjustment to surgery can be great, increasing
compliance and satisfaction, and resulting in faster recovery, thus placing
fewer demands on the health service (Kincey & Saltmore, 1990). Positive
responses to surgery can increase confidence, hope and self-esteem,
whereas negative responses can lead to anxiety, depression and low self-
esteem (Kincey, 1995). Surgical teams may find it difficult to assess a
patient's subjective experience of surgery as the correlations between
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subjective experience, overt behaviour and psychophysiology can be low
(Kincey & Benjamin, 1984). Further, Miller (1987) has identified two types
of coping responses to surgery, blunters and monitors. Monitors possess
and seek more information about their health and treatment procedures,
whereas blunters may be harmed by the presentation of 'unwanted'
information. These difficulties mean that there is no simple way to
predict the psychological outcome of surgery for an individual patient, and
that the surgical team should be sensitive to the harm that can be done by
routinely giving the same amount of information to every patient
(Schultheis et al., 1987). Certainly, a degree of information giving is
necessary in order to obtain informed consent for surgery, but much of the
additional information available is optional.
1.6.1. Psychological Reactions to Surgery - Issues Facing an OLT Candidate
The assessment procedure for OLT is a lengthy process, during which the
patient undergoes numerous investigations, from which the transplant
team make the decision whether or not the patient is a suitable transplant
candidate. If the patient is deemed a suitable candidate, it is ultimately the
decision of the patient and his or her family whether or not to go ahead
with the transplant process. This can be an agonising decision given that
the patient often has to decide to have a transplant when he or she is fairly
well, and may still have a life expectancy of a number of years, to give him
or herself the best chance of surviving the transplant surgery. Further, the
individual has to face the risk of death on the operating table.
1.6.2. Psychological Reactions to Surgery - Choice
Oncology literature provides tentative evidence that giving a patient a
degree of choice of treatment options improves their psychological
adjustment (Morris & Royle, 1988), although it must be noted again that
individual differences must be taken into account, and an assessment of
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the individual patient's coping style (blunter or monitor) is
recommended. Further, there is the risk that giving the patient a degree of
responsibility for the treatment decision could lead to them assuming
responsibility for treatment outcome. This becomes a problem if post¬
operative complications develop. Discussions about the risks involved in
the procedure are therefore fraught with psychological complexity. Ideal
practice involves providing opportunities for patients to gain information
and advice if they wish. There is some evidence that greater long-term
psychological disturbance occurs with major rather than minor surgery,
for example with oncological surgery (Maguire, 1985), and cardiovascular
surgery (Mumford et al., 1982).
1.6.3. Psychological Reactions to Surgery - Conclusions
It is clear that the factors affecting psychological outcome of surgery are
complex, including both patient characteristics and particular dimensions
of the surgery planned. Such dimensions include the extent to which
surgery may restore or remove function, change in life expectancy, change
in incidence of pain, change in the level of self-care, and the degree of
visible mutilation. In the case of liver transplantation, both positive and
negative outcomes along these dimensions may occur, complicating the
picture further. Symptom substitution may occur post-operatively, in that
the symptoms of chronic liver disease may be replaced with new
symptoms such as the side effects of immunosuppressant medication,
complications of the surgery or recurrent infections.
1.7. Quality of Life
Quality of life (QoL) is one of the most poorly defined and confusing
concepts in modern medicine (WHOQOL group, 1995). Some of the early
discussions of QoL saw it very much as a function of material well-being,
in other words how much money a person had (WHOQOL group, 1995;
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e.g. Harland, 1972). Since then the emphasis has shifted to include
objective measures, such as age, sex, education level, work status, and
subjective measures, that is the individual's perceived sense of well-being
in a number of domains. The first major studies equating QoL in these
terms, usually focusing on objective or subjective measures, attempted to
measure the QoL of samples of the general public (e.g. Krupinski, 1980;
Campbell, 1981). More recently, health-related QoL, in particular the
impact illness has on a person's functional status and happiness (Bergner,
1985), has been the focus of study. Interest in this field started with work
with cancer patients and the bulk of the literature continues to be with this
patient group. For a long time in health-care settings the primary aim of
medical intervention was increasing the duration of a person's life.
Morbidity (illness) and mortality were the only outcome measures used to
evaluate the effectiveness of a treatment (Bergner, 1989). The focus of QoL
work with cancer patients , however, has highlighted that living longer
was not necessarily the most important thing to the patient, and in fact
their QoL was often more important (Hunt et al., 1991; Morrow et al.,
1992). As a result of this work it has been slowly recognised in many fields
of medicine that goals of health care should be twofold: to increase the
duration of a patients life and to improve their QoL. Indeed, forty years
earlier the World Health Organisation seemed well ahead of its time
when it defined health as a state of physical, social and mental well-being,
not merely the absence of illness (WHO, 1958). Although this recognition
has been a major development in the philosophy of health care, the large
body of QoL literature to support the importance of evaluating treatments
in terms of QoL is generally fundamentally flawed. Most researchers
working on QoL, in whatever field, use their own, usually implicit,
definition of QoL. The subjective nature of QoL tends to elude strict
definition and makes a universal definition very difficult. Further, the
poor use of well validated and reliable measures of QoL makes
comparison of different studies difficult, and replication virtually
impossible. In addition, health-related QoL is not a steady state, but
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changes constantly with the adaptational process over the course of a
chronic illness and its treatment. Generally, in most studies at present,
QoL can be defined most typically to encompass physical, psychological
and social functioning (Aaronson et al., 1991).
1.7.1. Quality of Life Associated with OLT - Methodological Issues
The methodological difficulties described above are very apparent in the
emerging studies of QoL of orthotopic liver transplant (OLT) recipients.
As in other fields of medicine, over the past ten years there has been a
small surge of interest within liver transplant units to evaluate this major
surgery in terms of the recipients'QoL post-transplant. OLT is seen as the
treatment of choice for end-stage liver disease. Individuals suffering from
chronic liver disease may have led restricted lifestyles for a number of
years because of physical difficulties including pain, fatigue, chronic
itching, and neuropsychological difficulties due to hepatic encephalopathy
(described section 1.3.). Further, social difficulties and secondary mood
disturbance due to stress may be expected. Although very few studies
assessing QoL post-transplant have used the same measures, universally
positive results have been reported. A number of these studies, and
relevant issues as they arise, will now be discussed.
1.7.2. Quality of Life Associated with OLT - Studies that use Objective
Measures
Using the purely objective measures of return to work and need for
medical care, Lundgren et al. (1994) retrospectively investigated 197
transplant recipients. They reported that 64% had returned to work
between 6 and 12 months post transplant and only 1% still needed care in
an intensive care unit, compared to 17% and 23% respectively before they
received their transplant. The mean age of the sample was 36 years. The
authors concluded that OLT enhanced the recipients' capacity to work and
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diminished their need of medical care, thus improving their QoL.
Similarly, the QoL of 46 transplant recipients (including 15 infants, 13
adolescents and 16 adults) was assessed one year post-transplant by their
return to work or school (Starzl et al., 1979). The authors reported that
QoL of their sample ranged from poor to good. The methodological
difficulties of this study include no pre-transplant data, no control group
and the grouping of diverse age groups together. Another retrospective
study of 126 OLT recipients (mean age 44 years) assessed QoL, investigating
a new type of immunosuppressant medication, by the patients' ability to
work, and ability to take part in social activities, using a standardised
questions over the telephone (Felser et al., 1991). Positive results in both
domains were reported , and the authors concluded that the change in
medication had improved the QoL of the recipients interviewed. No
control group was included and no measures were taken before the change
in medication. In all of the above studies the use of objective indicators
assumes that they are valid indicators of QoL (Najman & Levine, 1981).
The evidence in the literature is that the relationship between objective
criteria for QoL and how an individual perceives his or her QoL is very
complex and therefore relying on objective criteria to make assumptions
about an individual's QoL is insufficient (WHOQOL group, 1994). The
above studies highlight the difficulties inherent in reviewing the field of
QoL research. The term QoL is used liberally without a clear
understanding of its multidimensional nature, and consequently the
danger is that over-enthusiastic conclusions can be reported about the
outcome of treatments.
1.7.3. Quality of Life Associated with OLT - Studies that Combine
Objective and Subjective Measures
Other studies combine objective and subjective measures, but still base
strong conclusions about the QoL of OLT recipients on the objective
measures, particularly returning to work. In a retrospective study with 46
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OLT recipients, mean age 46 years, Eid et al. (1989) assessed QoL in terms of
the patients' subjective sense of well-being (from simple questioning) and
their employment status. The recipients were interviewed between 13 and
31 months post transplant. Subjective well-being and satisfaction with life
were reported by 91% of recipients. Of the 46 recipients, 26 were employed,
16 were homemakers and 4 did not work. There are a number of
criticisms that can be made about this study. Firstly, no pre-transplant data
were collected, and no control groups were included. Further, the simple
subjective rating of well-being and satisfaction with life combined with
employment status are insufficient components of QoL. .
1.7.4. Quality of Life Associated with OLT - Studies that have used
Questionnaires Compiled by the Authors
Another group of studies have attempted to assess QoL in terms of the
patients' ratings of a number of dimensions, but have failed to use
standardised measures, which prevents replication and comparison of
results. In 26 OLT recipients (greater than 6 months post-transplant, mean
age withheld), QoL was assessed using likert-type scales on what is
described as a questionnaire compiled by the authors for the purpose of the
study (Foley et al., 1989). The authors reported that the sample
experienced a low number of side-effects of immunosuppressant
medication and 91% rated their QoL as good, very good or excellent.
Again, no pre-transplant data or control groups were included. Nicholas
et al. (1994) assessed QoL after OLT in 166 recipients (mean age 45 years) at
least one year post-operatively. The authors developed a five-part
questionnaire, the Rehabilitation Medicine QoL Instrument, to measure
the QoL of the sample. This included items about physical functioning,
endurance, vocational role and financial status. A high level of
musculoskeletal weakness was noted among the sample, although they
were able to perform activities of daily living well. Fewer recipients were
working than had been before their transplant, and this was linked to the
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musculoskeletal problems, marital status (more likely to be working if
married) and longer duration of liver disease. The same criticisms of no
control group and no pre-transplant data (employment status was assessed
retrospectively) apply to this study.
In a recent longitudinal, multicentre study, 346 adult transplant recipients
(median age 48) were assessed before and one year after OLT (Belle et al.
1997). The authors compiled their own QoL assessment battery by taking
particular items from a number of standardised instruments. They
assessed five domains: disease; psychological distress and well-being;
personal function; social/role function; and general health perception.
They reported improvements in all domains post-transplant, and
concluded that "... liver transplantation markedly improves the quality of
life of patients with end-stage liver disease.". The most common
distresses reported by the patients both before and after surgery were
fatigue and muscle weakness. Psychological distress was noted by 57% to
64% of recipients, although it was more likely to have decreased than
increased post-transplantation. The longitudinal design of this study
certainly aids interpretation of the results, although this is limited by the
lack of a control group. Further, the process of compiling a new
questionnaire from items from existing scales is a practice to be criticised as
no reliability of validity data have been established. The authors did,
however, supply the complete questionnaire in the appendix, which will
allow replication. Similarly, Levy et al. (1995) used a questionnaire, the
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases
liver transplantation QoL form (NIDDK QoL) in a prospective study
involving a total of 573 transplant recipients, at pre, 1,2 and 5 years post-
transplant. This was derived from items from a number of standardised
instruments: Karnofsky Performance Status Scale; Sickness Impact Profile;
Index of Well-Being; Medical Outcomes Survey; and the Nottingham
Health Profile. The authors noted that each of the above instruments
were designed to be administered by the interviewer, although the NIDDK
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QoL was self administered. Further, and of importance to the validity of
the data, no restrictions were placed or friends of family helping the
patients to fill out the form. Another significant limitation of this study
was the cross-sectional design, in that the same subjects were not serially
assessed. Rather, different groups of subjects at each time points were
assessed. Finally, no control group was included in the study. The NIDDK
QoL contained five sections: patient demographics; occupation; symptom
distress/frequency; activities of daily living; and impact of health on daily
life. Improvements in all domains were noted at each post-transplant
time point, particularly in perception of health status, self-image and
ability to function. The authors concluded that OLT leads to improved
QoL by one year post-transplant and this improvement is sustained by five
years post-transplant and beyond.
Comparing QoL in 10 individuals after liver transplantation for cancer
with 68 patients transplanted due to non-malignant diseases, Boudet et al.
(1995) used a number of indicators of QoL: side-effects of medication;
constraints of medical follow-up; and a self-report rating item from the
Sickness Impact Profile (see section 1.7.5.). They concluded that in terms of
the quality of life rating, there was no difference between the two groups
between 1 and 24 months post-transplant. 76% of the total sample rated
their QoL as normal. The authors noted that this was lower than figures
reported in previous studies, but within normal population ranges. The
measures used in this study were inadequate to equate QoL and no pre-
transplant scores or control groups were included.
1.7.5. Quality of Life Associated with OLT - Studies that have used
Standardised Measures
The final group of studies that will be discussed are those in which
complete standardised instruments have been used. The two most
commonly used instruments are the Sickness Impact Profile (SIP) and the
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Nottingham Health Profile (NHP). The SIP is a generic health status
instrument developed in the United States, measuring the impact of
disease on a patient's life. It includes a physical dimension, a psychosocial
dimension and a number of other categories: sleep and rest; eating; work;
home management; and recreation and pastimes. Its reliability and
validity are good (Bergner, 1993). The NHP is another generic health
status measure and consists of two parts. Part 1 includes energy, pain,
emotional reactions, sleep, social isolation and physical mobility. Part 2
includes employment status, jobs around the house, social life, family
relations, sex life, hobbies/interests and holidays. Validity and reliability
have been established (McEwan, 1993). The NHP has, however, been
criticised for focusing on problems and failing to reflect any positive
aspects (Bergner, 1985).
One of the most prolific research teams investigating the QoL of liver
transplant recipients is based at the University of Pittsburgh. A cross-
sectional design assessed QoL in 10 patients greater than 3 years post-
transplant (mean age 28 years) using the SIP (Tarter et al. 1984). A control
group of 10 individuals suffering from Crohn's disease (mean age 39 years)
was included, although no healthy control group was included. No
differences between the two groups were found, and impairments in sleep
and rest, eating and appetite, work capacity, and recreation and pastimes
were noted in the transplant group compared to population norms.
Omission of pre-transplant data limits the interpretation of these results.
A number of years later, Tarter et al. (1991) investigated QoL in 53 OLT
recipients prior to and again approximately 3 years post-operatively. The
SIP and the Social Behaviour Adjustment Schedule (SBAS, administered
to an informant of the patient) were used. A healthy control group, N=35,
was included although they only completed the SIP on one occasion.
Significant improvements across all dimensions and categories were
reported post-transplant, although some impairments did persist with
respect to social interaction, home management, recreations and pastimes,
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sleep and rest. Further significant improvements were reported on scales
of disturbed behaviour, social role performance and burden on the SBAS,
and at the post-transplant stage there were no differences in scores
between OLT recipients and healthy controls. The authors concluded that
OLT significantly improved QoL, although not to the level of functioning
of healthy individuals. Further, they concluded that at three years post-
transplant greater improvement was apparent in physical rather than in
psychological processes. The following year the same group again reported
improvements across almost all of the dimensions of the SIP greater than
2 years post-transplant, compared to pre-transplant scores (Tarter et al.,
1992). No control group was included in this study. Riether et al. (1992)
compared the QoL outcome of 61 liver transplantation recipients with that
of 51 heart transplant recipients using a battery of measures assessing
psychiatric status, cognitive functioning and QoL. QoL was assessed by the
SIP. The mean age of both groups was 46 years. The subjects were assessed
prior to their transplants and at three month intervals up to one year post-
transplant. Significant improvements on the physical, the psychosocial
and the overall scores of the SIP were recorded by both patient groups post¬
operatively. This study provides replicable evidence of improved QoL
post OLT, although it can be criticised for failing to include a healthy
control group and its conclusions must be limited to the first year post¬
operatively. After the first year change in the QoL of recipients may begin
to appear.
1.7.6. Quality of Life Associated with OLT - 'Faking Good'
'Postoperative euphoria' of transplant recipients has been described by a
number of workers (e.g. Leyendecker et al., 1993). Recipients have
described the feeling of being 'reborn' after surviving a transplant
procedure, particularly when they have been chronically ill for many years
and a transplant was their last chance of survival. Further, patients report
feeling indebted to the organ donor, their family for the support they have
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given, and to the transplant team. This point is important in the field of
QoL research, where it is highly possible that recipients feel pressured into
reporting that they feel great. They may feel guilty if they admit to the
medical team who saved their lives that they are having problems. This is
particularly important given the publicity given to the high cost of
transplant procedures. Finally, it may be that transplant recipients exhibit
a degree of denial and find it hard to communicate their fears about organ
rejection. It is likely that more useful information about the QoL outcome
of transplantation would be gained at a later postoperative stage, when the
recipients may feel more able to be truthful about any difficulties that they
are experiencing.
1.7.7. Quality of Life Associated with OLT - Problems with Measurement
The NHP was used to assess QoL in 58 OLT recipients (mean age 42) in a
cross-sectional design including three time points: less than a year, 1-2
years and more than 2 years (Lowe et al., 1990). Overall the results
indicated that QoL was high in OLT recipients, equivalent to age and sex
matched general population norms (no control groups were included in
the study). The authors acknowledged that the NHP is weighted to
negative aspects of health, and highlighted that many of the recipients
indicated that it gave the no opportunity to comment on the positive
aspects of their experiences. It can therefore be concluded that the NHP is
an insufficient measure to assess QoL in this patient group, masking
positive aspects and perhaps also insensitive to subtle changes in QoL
experienced. Further, the results would carry more weight if a prospective
design had been used. A further study reporting results from the NHP
assessed 27 OLT recipients, 71 patients with chronic liver disease assessed
for transplant but not yet transplanted and 11 rejected for. transplantation
(Price et al., 1995). They were prospectively assessed at 3-6, 9-12, and 15-24
months post-transplant. Results indicated that over 2 years post-
transplant QoL, as assessed by the NHP, improved and became broadly
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similar to that of the general population (no healthy control group was
included). Over the same period, very little change was observed for the
non-transplant group. The authors highlighted that the two groups
differed in the diagnostic mix, severity of liver disease and their QoL at the
beginning of the study, and therefore it cannot be assumed that the QoL of
patients in the non-transplant group would have improved had they
undergone transplantation. Transplant recipients, despite rating their
overall health as good, did experience a number of problems with pain,
mobility and looking after the home. No statistical analyses of the data
were presented and no pre-transplant data were available. It was
concluded that OLT improved QoL but not to optimal levels.
A Dutch group investigated QoL in 46 adult OLT recipients, some of
whom were assessed serially, pre- and yearly post-transplant, and some
assessed at one time point only (Bonsel et al., 1992). The researchers
combined the data from both groups in a cross-sectional analysis. A
computer assisted battery of assessments were used to examine QoL and
psychiatric status. QoL was measured by the NHP, the Karnofsky index
which is a global one-item measurement of health status (not designed as
a QoL measure although often used as one), and the Index of Well-being
which is a global measure of experienced well-being. Further, they asked
specific questions about the following areas: activities of daily life; physical
complaints; and satisfaction with health, leisure time, daily activities and
life as a whole. The authors noted that pre-transplant scores suggested
restrictions in all domains of life, especially low energy levels. There were
improved scores in all the assessments used post-operatively, although
not to the level of general population norms. Due to the relatively small
sample size given that different patients were assessed at each time point,
and the lack of any control groups, interpretation of this data must be
made with extreme caution. This study also highlights another difficulty
when evaluating QoL research, namely that the use of QoL measures
translated for use in different languages is a practice open to criticism.
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Fletcher et al. (1992, pp. 1145-1146) described the problems as follows:
"Researchers should be wary of using an instrument in a cultural setting
different from that in which it was developed. Apart from face or content
validity, other problems include the validity of the translations and the
relative importance of items in the instrument." Another study which
used translated measures investigated the following: physical and
psychological status; physical complaints; capability to participate in daily
life; social support; and global QoL in 45 OLT recipients an average of 9
months post-transplant (Leyendecker et al., 1993). A German translation
of the Psychological General Well-Being Index, including a number of
adaptations, was used and global QoL was measured by means of a visual
analogue scale. Assessments of mood and social support are discussed
elsewhere (see sections 1.8. and 1.10. respectively). Results indicated that
QoL in the first year post-transplant was good: 60% high, 31% medium and
9% very bad. Those who were actively working again reported feeling
best. Positive subjectively reported QoL occurred despite a high number
of physical complaints. Thus the authors concluded that .an improved
QoL is not implied merely by absence of complaints. As with most studies
described above, no pre-transplant data and the lack of a control group
limit the interpretation of these results.
Chen & Sun (1994) take the view that simple and concise measurement of
QoL is preferable to the use of complicated instruments, indicating that in
their view standardised instruments are unnecessary. Unfortunately,
although standardised instruments may be complicated, it is only through
their use that we can compare findings across groups, and that
conclusions about the QoL of transplant recipients can be made with
confidence. They used the Karnofsky index and the Zubrod-ECOG-WHO
as well as a number of medical objective measures, such as liver and renal
function, and number of postoperative infections to assess QoL in 7 young
OLT recipients (mean age 20 years). The mean time since transplant was
40 months (ranging from 2-8 years). The authors did not carry out any
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statistical analysis of results, but concluded that the majority of patients
showed a high degree of satisfaction and enjoyed an "excellent" QoL with
complete rehabilitation after OLT. These are clearly over-enthusiastic
claims given the methodological flaws of the study. The sample size was
very small (N=7, including one pre-school child) and no control groups
were included. Further, the time since transplant varied considerably and
no pre-transplant data were included. Finally, the assessment measures
were insufficient indicators of QoL.
1.7.8. Quality of Life - Development of New Measures
A disease specific QoL measure, the European Organisation for Research of
Treatment of Cancer (EORTC), was modified for use with a liver disease
population by Kuchler et al. (1991) who presented results from 12 OLT
recipients. This measure includes items on: functional status; ability to
work; general symptoms; symptoms specific for liver disease; anxiety;
depression; social integration; treatment strain; overall physical condition;
and overall quality of life. Unfortunately demographic data on subjects
were incomplete. Further, a healthy control group and a chronic liver
disease control group were assessed on one occasion but again no data
were included. Data were collected from two transplant centres; Chicago
and Flamburg. Patients from the former centre were assessed at 3, 6, 12, 24
and 36 months after OLT (N=38). Patients from Hamburg were assessed
pre- and 2, 6, 12, 24 and 36 months after transplantation (N=9). Results
indicated that successfully transplanted subjects perceived their overall
QoL as significantly improved after transplantation, as high as the healthy
controls and better than the chronic liver disease patients. Perception of
their overall physical condition also improved post-transplant although
not to the levels of the healthy controls. The interpretation of results
from this study is limited by the poor reporting of demographic data of the
patients and controls. Further, the combination of results from two
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centres must be undertaken cautiously given the different languages
involved and the timing of assessments.
A number of health and psychosocial measures were used to investigate
QoL in 41 OLT (mean age 44 years) recipients between 4 and 36 months
post-transplant (Wolcott et al., 1989). The Index of Weil-Being and the
Simmons Scale of self-esteem were combined with a number of direct
questions about: current life satisfaction; illness-related stressors;
vocational activity; social/leisure activities; social support; global health;
activity restrictions; physical symptoms; and recent use of health services.
Neuropsychological assessments were also used and were discussed
elsewhere (see section 1.3.4.). Positive life satisfaction was reported in all
domains except work, career and sexual activity. High self-esteem was also
reported, and the most stressful areas were reported to be related to
financial matters and medical treatment. Finally, 75% rated their health as
good or better, although 80% and 48% had some restriction in rigorous
activity and moderate activity respectively. The main criticism of this
study (aside from lack of control groups and no pre-transplant data) was
the wide range of transplant to assessment intervals included in the
sample. Additionally, no statistical analysis was reported on the data.
1.7.9. Quality of Life - Summary of Issues Associated with OLT Research
In conclusion, there have been a number of studies assessing QoL
associated with liver transplantation recipients. Many of them, however,
are methodologically flawed: they are often retrospective; lack control
groups; use unreliable and invalid measures of QoL; and employ small
sample sizes. Perhaps the most important criticism is the practice of
making unrealistic conclusions about the QoL of OLT recipients, given the
above flaws. Heterogeneous groups of subjects, for example with vastly
varying times since they received their transplant, is also a criticism of
many studies. The better studies have acknowledged that an
improvement in QoL does occur post-transplant, although not to levels
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observed in the general population. Finally, the problem of recipients
reporting a better QoL due to gratitude to the transplant team must be
acknowledged.
1.8. PsychologicalDysfunction Associatedwith Liver
Transplantation
As well as the neuropsychological difficulties concurrent with HE, the
emotional accompaniments of liver disease are assuming greater
importance given the improved prognosis provided by OLT. Studies
assessing the emotional well-being of those suffering from liver disease
have focused on anxiety and depression in transplant recipients. Some of
these studies are prospective and therefore include pre-transplant data,
giving an indication of the mood state of those suffering from chronic
liver disease. Generally, however, the assessment of mood in OLT
populations is limited.
1.8.1. Psychological Dysfunction in Oncological Populations
In contrast, there is a large body of literature documenting high levels of
anxiety and depression in oncological patients (Peck & Bolond, 1977;
Forester et al., 1978; Greer, 1984; Palmer et al., 1980). Most of these studies
concluded that anxiety and depression were associated with the treatments
the patients were undergoing (chemotherapy and radiotherapy). Other
researchers have found emotional distress in cancer patients to be more
related to situational factors, such as home support and other stresses,
rather than illness (e.g. Weisman, 1976). Hinton (1984) found that the
longer the illness the greater degree of emotional disturbance to be
expected. Maguire (1984) has highlighted the under-diagnosis of
psychological disturbance in cancer patients, and suggested the use of
specially trained doctors or nurses to help to identify those at risk, as well
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as those already suffering from psychological disturbance, in those who are
seriously ill.
1.8.2. Problems in Assessing Psychological Disturbance in Physically 111
Populations
One major problem in assessing psychological disturbance in physically ill
populations is that many of the items used to indicate morbidity in the
general population occur as accompaniments to serious illness, such as
fatigue, loss of appetite and sleep disturbance. The Hospital Anxiety and
Depression Scale (HADS) was developed specifically for use with medical
patients, excluding somatic features (Zigmund & Snaith, 1983). It is
extremely easy to score and administer, and is extensively used in many
settings, providing evidence of good validity and reliability.
Unfortunately, most of the studies assessing psychological disturbance in
the liver disease population have used scales measuring mood that still
include somatic items, weighting them towards those who are physically
ill. Therefore results must be interpreted with caution, as there is a risk of
over-reporting of psychological disturbance.
1.8.3. Studies Assessing Psychological Disturbance in OLT Populations
The Beck Depression Inventory (BDI) and the State Trait Anxiety
Inventory (STAI) were used to assess emotional status in 9 heart and 11
liver transplant recipients pre- and at 3 month intervals up to 1 year post-
transplant (Riether et al. 1992). The authors noted significant
improvements in depressive symptoms after transplantation in both
groups. Mild to moderate anxiety was also present in both groups, which
dropped considerably at 3 months before rising again at 6 and 12 months
post-operatively. The STAI and the Zung Self-rating Depression Scale
were used to assess emotional status in 52 OLT recipients, 26 whom were
tested at one time point post-operatively and 26 whom were assessed
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prospectively pre- and 3 months post-transplant (Bonsel et al., 1992).
Three months post-operatively there was a significant improvement in
depression scores, although no control group was included for
comparison. No change in reported anxiety was found. Using open-
ended psychiatric interviews, House et al. (1983) assessed the psychiatric
status of 20 adult OLT recipients pre- and post-operatively (ranging from 6
months to 12 months since transplantation). According to DSM III
criteria, they found that pre-transplant 95% of patients experienced
significant psychiatric distress, which rose to 100% post-operatively. The
most common problems were organic brain syndromes, anxiety and
depression. In contrast, the authors reported that using the same criteria,
17% pre- and 32% postoperative kidney transplant recipients experienced
significant psychiatric distress. There were no control groups included in
this study and the times since transplant varied considerably, therefore
masking any changes in psychiatric morbidity in this group over time.
Finally, the open-ended questioning technique is open to criticism given
that no validity or reliability was established, and replication of the study
is not possible. The use of standardised assessment measures must be
recommended.
The Profile of Mood States (POMS) has also been used. Wolcott et al.
(1989) used the POMS with 41 OLT recipients, between 4 and 36 months
post-transplant, and reported minimal mood disturbance in this group.
No pre-transplant data or control group were included. In a prospective,
controlled study, Moore et al. (1992) assessed 9 OLT recipients, and 9 well
matched controls at the same intervals, pre-transplant and 30 days, 3 and 9
months post-operatively. A decrease in tension, depression, confusion,
anger and fatigue, and an increase in vigour were found in the OLT group
post-operatively. There were no changes found in the control group.
Psychological dysfunction has also been reported in other studies as a
component of quality of life scales. Using the EORTC QoL questionnaire,
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which has components of anxiety and depression included, Kuchler et al.
(1991) assessed 12 patients pre- and 3, 6,12, 24 and 36 months post¬
operatively (although not all patients were assessed at every time point).
Healthy controls were also assessed at one time point, but no data were
included to indicate how well matched they were. They found that
transplant patients experienced higher anxiety than the control group, and
that it stayed high post-operatively, even at three years. They also noted
that reported anxiety increased immediately in any crisis situation, for
example in situations of infection or rejection. Depression, on the other
hand decreased with time post-transplant. The authors also reported a sex
difference in that women reported less depression, which is in contrast
with elevated levels of depression in women compared to men in the
general population. The small sample size and lack of statistical analysis
limit the usefulness of the results presented in this study, although it
highlighted a number of interesting points that require further
investigation.
Finally, Tarter et al. (1984) reported on the mood components of the
Minnesota Multiphasic Personality Inventory (MMPI) and the Sixteen
Personality Factors Questionnaire (16PF) in 10 OLT recipients (3 years post-
transplant) and 10 controls suffering from Crohn's disease. No differences
were reported between the two groups, although compared to population
norms, the OLT group displayed higher anxiety, somatic distress,
depression, worry and social withdrawal. The transplant recipients in this
study were relatively young, with a mean age of 28 years, and no
information is available about the change in mood over time.
1.9. Self-Esteem
Self-esteem can be defined as the perception an individual possesses of his
or her own worth (Hattie, 1992; Rosenberg, 1989). Elements of self-esteem
include genetic influences combined with the impact of life experiences
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(Battle, 1990). Generally, however, self-esteem is a fairly undefined
concept, often confused with the wider domain of self-concept, or the
more specific self-perception of body image (Brinthaupt & Erwin, 1992). In
the field of health psychology, self-esteem has been described as a
mediating resource in the psychological adjustment to illness (Rosenberg,
1989). There has, however, been little research into the role of self-esteem
in populations with life-threatening illnesses, and very little in the field of
psychological outcome to liver transplantation. The present study aims to
assess the self-esteem of OLT recipients to establish if it is equivalent to
that of healthy subjects. Wolcott et al. (1989) used the Simmons scale of
self-esteem with a group of 41 liver transplant recipients between 4 and 36
months post-transplant, and reported levels of high self-esteem. Given
that the definition of self-esteem is the individuals' perception of their
own worth, the return of healthy functioning post-transplantation and the
sense of a "new life" may predict that OLT recipients would have a higher
self-esteem than liver disease controls. The relationship between low, or
high, self-esteem and health is unknown.
1.10. Social Support
The concept of social support in relation to coping with health problems is
complex. A number of studies have found that a positive appraisal of
social support has been related to positive emotional adjustment to
illness, as well as important health-related outcomes, including mortality
(Namir et al., 1989; Vanderplate et al., 1988). As in many fields of health
psychology research, the bulk of the literature focuses on oncology
populations, but much of the work can be generalised to other life-
threatening illnesses. It is now well recognised that various forms of
social support exist for an individual. A good distinction, particularly
relevant to chronically ill populations, is that of emotional and practical
support (Power et al., 1988). These authors have also distinguished
between actual and ideal levels of social support, and the importance of
38
any discrepancy between these. This approach to social support allows the
adequacy of social support functions to be analysed, rather than just the
number, type and organisation of an individuals support system. It has
been postulated that the type of support needed by an individual changes
over time, and as stages of illness progress (Britton et al., 1993). Therefore
the adequacy of support will depend on the extent to which changing
needs are met by significant others. Indeed there is good evidence that an
individual can influence the nature of the social support they receive
(Dunkel-Schetter et al., 1987). In work with cancer patients, this group
found that the adoption of a positive attitude was a conscious effort to
elicit support from others (Dunkel-Schetter & Wortman, 1982). The
nature of the relationship between social support and health may be
bidirectional. That is, good social support may lead to better health
outcomes, and vice versa (Gotlib & Hooley, 1988). The cancer literature
sheds further light on the relationship between social support and health
with evidence that one of the worst stresses reported by patients is the
breakdown of social contacts, during a time when the need for support is
heightened (Gore, 1981). Two effects of social support have been described,
direct and indirect (Cohen & Wills, 1985). Direct effects reduce stress
responses of the individual by changing their perceptions and cognitions
of the threat they face, or by changing physiological processes at a result of
decreased tension or increased relaxation. Indirect effects of social support
include bringing about changes in the individual's health-related
behaviour, for example by reducing alcohol consumption. The role of
social support in adjustment to liver transplantation has received little
attention. The importance of social support in this group of patients must
be understood in the context of the impact of a debilitating chronic illness,
with associated role losses due to fatigue and other symptoms. The need
for practical support may be great. In contrast, the transplant process may
necessitate a greater need for emotional support. Post-transplant, the need
for support may be complex, with the individual hoping to regain much
of the practical and emotional independence they had prior to their
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illness. Added to this, coping responses such as denial (see section 1.7.6. )
may mask their true need for support. This study aims to assess transplant
recipients' perceptions of the quality of their social support, and to assess
the relationship between inadequate (too much or too little) social support
and QoL.
1.11. Overall Conclusions
The neuropsychological impairment associated with latent hepatic
encephalopathy is now well documented. A number of studies have
shown that performance on neuropsychological tests improves post-
transplant. The quality of life of transplant recipients has received a great
deal of interest in the literature, although due to its poorly defined nature,
and methodological flaws in many studies, conclusions must be drawn
with caution. QoL does seem to improve after a liver transplant, although
not to the levels found in the healthy population. Very few studies have
looked directly at changes in anxiety and depression post-transplant, and
those that have tended to use scales that are inappropriate for use with
physically ill populations. The time since transplant has been ignored by
many studies, with the inclusion of patients at vastly different times since
transplant. The majority of studies have included patients within the first
year post-transplant. It may be that the above variables change at different
rates, and it must be acknowledged that changes found may be limited to
certain phases post-transplant.
It is clear that there is a need for well controlled, prospective research into
the psychological outcome of liver transplantation. OLT is a procedure
which involves great risk to the patient, not only in terms of dying on the
operating table with a life expectancy of a number of years, but also of
months of risk of infection or rejection. A lifetime of strict drug regimens
is also a major adjustment. Nevertheless, successful OLT can dramatically
restore an individual's health, and their associated roles and activities.
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For most people, psychological issues are paramount, and can often be
overlooked by those around them. It is essential that QoL, mood and
neuropsychological function are adequately assessed in these individuals,
and that their psychological needs are met. The importance of establishing
mediating factors to psychological adjustment to liver transplantation is a
further research challenge.
1.12. Aim of the Present Study
The major aim of the present study is to investigate the psychological and
cognitive sequelae of liver transplantation. A prospective design was used
to assess OLT recipients pre- and 3 years post-transplantation. A liver
disease control group, who have not undergone OLT, and two healthy
control groups have been included. The following hypotheses were tested:
1.13. Hypotheses
1. Liver transplant recipients will have improved on mood (anxiety and
depression), quality of life and neuropsychological measures.
2. The liver disease control group will have deteriorated on mood, quality
of life and neuropsychological measures.
3. The healthy control group will show no change on mood, quality of life
and neuropsychological measures.
4. Self-esteem of liver transplant recipients will match that of healthy
controls, whereas liver disease controls will have lowered self-esteem.
5. Transplant recipients will have a more positive acceptance of illness
than chronically ill liver disease controls.
6. Inadequate perceived social support will be associated with poorer QoL




A repeated measures experimental design looking for both within group
differences, and between group differences, on a number of measures was
used to assess the long-term psychological and cognitive impact of liver
transplantation. Subjects were assessed at two time points, between 3 and
5 years apart. Four groups were included in the study: liver transplant
recipients (Tr), chronic liver disease controls (LC) and two healthy control
groups, one included in both repeated and cross-sectional analysis (HC 1),
and a better matched group included in the cross-sectional analysis only
(HC2).
2.2. Subjects
A total of 78 patients with liver disease attending the Royal Infirmary of
Edinburgh for treatment underwent the initial assessment for the study
(Time 1) between 1993 and 1994. Of this group, 28 subsequently underwent
liver transplantation. The mean time between transplantation and
follow-up assessment was 37.4 months (sd=10.5). At the follow-up stage
(Time 2), confirmation of whether each person was alive or dead was
obtained, and it was found that 7 of the transplanted group and 28 of the
non-transplanted group had died since the initial recruitment for the
study. A Chi squared test indicated that the difference in mortality rates
between the two groups (Tr and LC) was significant (x=6.97, p<0.01). The
remaining patients, 21 liver transplant recipients and 22 chronic liver
disease controls, were contacted by post asking them whether they would
take part in the follow-up assessment (see Appendix 1 for letter). Self-
administered questionnaires (see Chapter 2), a consent form (see Appendix
2) and a postage paid reply envelope were included. Positive replies were
received from 16 liver transplant recipients and 11 non-transplanted
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patients. One transplant recipient did not wish to take part in the study.
Appointments were then arranged to meet with those who agreed to take
part in the study to carry out the neuropsychological assessment. At this
point one of the non-transplanted patients had died since completing the
self-administered questionnaires, one transplant recipient lived in
Northern Ireland and it was therefore impossible to arrange a meeting,
and one transplant recipient and one non-transplanted could not be
contacted. The final samples therefore included 16 liver transplant
recipients (14 of whom completed the neuropsychological assessment) and
11 non-transplanted controls (9 of whom completed the
neuropsychological assessment). All patients had biopsy confirmed liver
disease at the initial assessment stage.
Table 2: Liver disease characteristics of transplanted and non-transplanted
groups.
Liver disease characteristic Transplant Liver disease X P
group control group
A 0 1
Child's B 9 7 0.49 NS














Chronic active 2 2
hepatitis
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Chi squared tests were carried out to determine whether the transplant
group (Tr) and the liver disease control group (LC) were matched in terms
of liver disease characteristics at Time 1 (see Table 2). These indicated that
the distribution of the severity of liver disease, and the proportion of
alcoholic cirrhotics, included in the two groups (Tr and LC) were not
significantly different.
A total of 12 healthy controls took part in the initial assessment for the
study and were contacted, and agreed, to take part in the follow-up study
(healthy control group 1). Healthy control group 1 was matched to the
liver transplant group by sex, but was poorly matched by age, years in full
time education and estimated full scale IQ. A further group of 11 healthy
controls (matched by sex, age, years in full time education and estimated
full scale IQ) were assessed at the follow-up stage only (healthy control




Demographic variables including: sex, age, educational level and
estimated full scale IQ were obtained. Details of type and severity of liver
disease were also obtained at the initial assessment stage (see Table 2).
Severity of liver disease was calculated according to the following criteria:
serum albumin level; serum bilirubin level; prothrombin time; presence
or absence of encephalopathy; and presence or absence of ascites. Results
indicate the level of liver disease as A (mild), B (moderate) or C (severe).
Full scale IQ was estimated by the National Adult Reading Test (NART,
Nelson & Willison, 1987). This test is very easy to administer, requiring
oral pronunciation of a list of 50 irregular words. It is a particularly good
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test to estimate premorbid intelligence levels, being relatively resistant to
cognitive impairment. High internal reliability of 0.93 has been reported
(Nelson & Willison, 1991), and inter-rater reliability has been found to be
equally high between 0.96 and 0.98 (O'Carroll, 1987). Finally, a test-retest
reliability co-efficient of 0.98 has been reported (Crawford et al., 1989).
2.3.2. Self-administered questionnaires
2.3.2.1. The Rotterdam Symptom Checklist (RSC, De Haes, 1986,
Appendix 3).
Quality of life data were obtained using a modified version of the RSC.
This questionnaire was originally developed for use with oncology
subjects. It consists of 8 psychological and 19 physical items. The physical
component was modified by the present researcher for use with liver
disease subjects by extracting oncology-specific items and substituting them
with the most commonly reported liver disease-specific physical
symptoms. Psychological items were unchanged as they were designed for
non-specific illness populations. At the time of the initial recruitment of
subjects, use of the RSC with illness populations was recommended by the
Medical Research Council (McGuire & Selby, 1989).
Subjects were asked to rate each symptom ( psychological and physical) on
a 4 point scale (not at all, a little, moderately, very much) according to how
they have felt over the past week. Scores of psychological QoL range from
8-19, and scores for physical QoL range from 19-45.
2.3.2.2. The Hospital Anxiety and Depression Scale (HADS, Zigmond &
Snaith, 1983, Appendix 4).
This is a well established British scale which has been used as a screening
instrument for anxiety and depression in non-psychiatric populations.
High internal consistency of the HADS has been reported(Cronbach's
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alpha = 0.93 for anxiety and 0.90 for depression, Moorey et al, 1991). It
consists of two 7 item scales in which subjects answered questions
indicating their response on a 4 point scale. Scores range from 0-21 for
anxiety and depression, with a score of 10 or above generally taken as
indicative of "caseness".
2.3.2.3. Rosenberg Self-Esteem Scale (RSE, Rosenberg, 1989, Appendix 5).
The RSE is a widely used in healthcare as a measure of global self-esteem.
It consists of ten items which the subject is asked to rate on a four point
scale. The scores range from 10-40, with a high score indicating high self-
esteem. Test-tetest reliability has been reported to be 0.63 (Byrne, 1983).
2.3.2.4. Acceptance of Illness Scale (AIS, Felton et al, 1984, Appendix 6).
The AIS measures the extent to which an individual is able to accept their
illness without experiencing negative feelings or responses. The authors
(Felton et al., 1984) of the scale have demonstrated high internal
consistency (Cronbach's alpha = 0.81 to 0.83) and a reasonably high test-
retest reliability over a seven month period (Spearman's rho = 0.69). The
scale includes eight items on which subjects rated the extent to which they
agree of disagree with statements about their illness on a 5-point scale.
This scale was not used with the healthy control groups. Scores range
from 8-40, with a high score indicating good acceptance of illness.
2.3.2.5. Significant Others Scale (SOS, Power et al, 1988, Appendix 7).
The SOS is designed to measure the quality of the support provided by
significant others in an individual's social network. Test-retest reliability
across the scores of social support over a six-month interval ranged from
0.73 to 0.83 (Power et al, 1988; Power & Champion, 1992). Subjects were
asked to specify up to seven important people in their lives and then
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asked to rate, on a seven point scale, two questions on the level of
emotional and then practical support that each person provides. Subjects
were also asked to rate the ideal levels of emotional and practical support
wished for each person specified. The discrepancy between actual and
ideal support for each person specified can then be calculated. Mean scores
for actual and ideal, emotional and practical support range from 1-7.
2.3.3. Repeated Neuropsychological Measures
2.3.3.1. Rivermead Behavioural Memory Test (RBMT, Wilson et al, 1989).
The RBMT is a valid measure of everyday memory difficulties which
includes four matched parallel versions to control for practice effects. Two
parallel versions were used in the present study, at Time 1 and Time 2. It
consists of a number of sub-tests designed to map directly onto a
component of everyday memory. Scores range from 0-24.
2.3.3.2. The Digit Span subtests of the Wechsler Adult Intelligence Scale -
Revised (DF & DB, Wechsler, 1981).
This subtest comprises two components, Digits Forward and Digits
Backward. Both tests involved the administration of two trials for each
span length of a series of random numbers. Digits Forward span length
ranges from three to nine consecutive numbers, and Digits Backward two
to eight consecutive numbers. Both tests measure auditory attention and
immediate verbal recall, although Digits Forward involves a larger
component of efficiency of attention, and Digits Backwards is a more
demanding task and involves a larger component of working memory.
Both tasks have been shown to be sensitive to brain damage, although
Digits Backwards is more so (Lezak, 1983, pp266-270). For "each subtest,
scores range from 0-14.
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2.3.4. Neuropsychological measures assessed at Time 2 only.
The neuropsychological functions assessed at Time 1 were limited to
attention and memory. In order to extend the range of neuopsychological
functions assessed, two further tests were added at Time 2. The Digit
Symbol Substitution Test was included to measure psychomotor
performance, and verbal fluency was added to measure executive
functioning.
2.3.4.1. The Digit Symbol Substitution Test of The Wechsler Adult
Intelligence Scale - Revised (DSST, Wechsler, 1981).
This test consists of a series of small blank boxes paired to a randomly
assigned number from one of nine. Each number is matched to a symbol,
and the subject is asked to fill in the corresponding symbol, paired to each
number, in the boxes as quickly as possible. The subject is stopped after 90
seconds. This test measures psychomotor performance, and is relatively
unaffected by memory and learning (Lezak, 1983, p273). It has been shown
to be particularly sensitive to even minimal brain damage (Hirschenfang,
1960). Further, this test is particularly sensitive to the cognitive
impairment associated with liver disease (O'Carroll et al., 1991). Scores
range from 0-93.
2.3.4.2. Verbal Fluency Test (VFT, Benton et al, 1983)
Verbal fluency is the speed and ease of verbal production and is a measure
of executive functioning. It is most commonly measured by word naming
tests. The most common format involves three word-naming trials in
which the subject is asked to name as many words as possible beginning
with the letters FAS. This test has proven to be a sensitive indicator of
brain dysfunction (Benton, 1968).
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2.4. PROCEDURE
At the initial assessment stage (Time 1), all tests and questionnaires were
administered to subjects during an interview at the Royal Infirmary of
Edinburgh. The interview lasted between 1 and 2 hours and the tests were
administered in the following order: RBMT; DF, DB; HAD, RSC.
At the follow-up stage (Time 2), the self-administered questionnaires were
sent by post (see section 2.3.2.). The neuropsychological assessment was
carried out during an interview with the researcher either at the Royal
Infirmary of Edinburgh or at the subject's home (see sections 2.3.3. and
2.3.4). The interview lasted approximately 1 hour and the tests were
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35.8 (4.9) 35.2 (6.5) 49.1 (5.8) NA* 22.6 0.000 HClcTr,
LC
* NA = not applicable
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Demographic data on subjects in the four groups (Tr, LC, HC1 and HC2)
are presented in Table 3.
One-way ANOVAs, with four groups, indicated that there were significant
between group differences in age, years in education and months between
assessments (Table 3). To establish which groups were different, Scheffe
tests, (significance level, p < 0.05), were used, which significantly
differentiated the healthy control group 1 from the other groups on these
variables. There were no significant differences in sex (using a Chi
squared test) or full scale IQ between any of the groups. The transplant
group (Tr), the liver control group (LC) and the healthy control group 2
(HC2) were not significantly different on any of these measures.
3.2. Repeated Measures Analyses
These analyses included three groups: liver transplant group (Tr); liver
disease control group (LC); and healthy control group 1 (HC1). Repeated
measures analyses included two time points: initial assessment (Time 1);
and follow-up assessment (Time 2).
3.2.1. Quality of life
3.2.1.1. Psychological Component
A repeated measures analysis of variance (ANOVA), with two time
points and three groups, indicated that there was a significant, overall
difference in psychological quality of life between the three groups.
Examination of the means indicated that the healthy control group had a
better psychological QoL than both of the liver disease groups (see Table 4).
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Table 4: Change in scores of psychological component of QoL.
Group Time 1 Time 2
Mean (SD) Mean (SD)
Liver
Transplant 17.4 (4.6) 15.5 (6.0)
Liver
Control 14.7 (4.4) 15.8 (7.3)
Healthy
Control 1 12.1 (2.9) 11.2 (2.4)
Group Effect F=4.38, p=0.020
Time Effect F=0.37, p=0.547
Interaction F=0.91, p=0.412
There was, however, no effect of time and no interaction between the
groups over time. It is notable that the largest change in scores over time
was the improvement in scores of the transplant group.
Comparison of means at Time 2
All four groups were compared at Time 2 to assess whether the
psychological QoL of transplant recipients 3 years post-transplant was
different to that of healthy or liver disease controls. A one-way ANOVA,
with four groups (including healthy control group 2), indicated that no
two groups were significantly different on scores of psychological QoL at
Time 2 (see Table 5).
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15.5 (6.0) 14.7 (6.6) 11.2 (2.4) 13.5 (3.8) 1.72 0.1774 -
Physical
QoL 31.6 (9.4) 40.2 (14.5) 22.3 (2.2) 27.3 (6.6) 7.25 0.0005
LC>HC1,
HC2
Anxiety 5.9 (4.1) 5.2 (5.7) 4.5 (3.9) 6.8 (3.4) 0.60 0.620 -
De¬
pression 3.5 (3.2) 4.6 (4.2) 0.9 (1.8) 2.5 (2.6) 2.86 0.047 -
Memory
(RBMT) 20.4 (2.7) 18.8 (3.7) 21.2 (1.8) 21.5 (3.0) 1.92 0.164 -
Digits
Forward 8.0 (2.5) 9.7 (3.3) 10.5 (1.7) 10.8 (2.1) 3.44 0.025 -
Digits
Backward 6.7 (2.8) 7.9 (3.0) 8.5 (2.5) 8.8 (2.2) 1.61 0.2023 -
3.2.1.2. Physical Component
A repeated measures ANOVA, with two time points and three groups,
indicated that there was a significant overall difference in physical quality
of life between the groups (see Table 6). Again, examination of the means
indicated that the healthy control group had a better physical QoL
compared with both of the liver disease groups.
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Table 6: Change in scores of physical component of QoL.
Group Time 1 Time 2
Mean (SD) Mean (SD)
Liver
Transplant 34.9 (7.9) 31.6 (9.4)
Liver
Control 40.2 (11.9) 40.91 (14.0)
Healthy
Control 1 23.0 (2.9) 22.3 (2.2)
Group Effect F=13.03, p=0.000
Time Effect F=0.61, p=0.440
Interaction F=0.75, p=0.478
There was no effect of time and there was no interaction between the
groups over time, although the largest change in scores was the
improvement in scores of the transplant group.
Comparison of means at Time 2
A one-way ANOVA, with four groups (including healthy control group 2),
indicated that there was a significant difference between the groups on
scores of physical QoL (see Table 5). A Scheffe test, p<0.05, indicated that
the physical QoL of the liver disease control group was significantly worse
than that of both of the healthy control groups. The liver transplant group
did not differ significantly from any group 3 years post-transplant.
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3.2.2. Anxiety
A repeated measures ANOVA, with two time points and three groups,
indicated that there was no significant overall difference in anxiety
between the groups (see Table 7).
Table 7: Change in scores of anxiety.
Group Time 1 Time 2
Mean (SD) Mean (SD)
Liver
Transplant 7.5 (4.6) 5.9 (4.1)
Liver
Control 6.3 (3.8) 5.8 (4.7)
Healthy
Control 1 5.6 (3.0) 4.6 (3.9)
Group Effect F=0.63, p=0.537
Time Effect F=2.05, p=0.161
Interaction F=0.25, p=0.781
There was no effect of time and there was no interaction between the
groups over time. Again, however, the largest change in scores over time
was the improvement in scores of the transplant group.
Comparison of means at Time 2
All four groups were compared at Time 2 to assess whether anxiety scores
of transplant recipients (3 years post-transplant) were different to those of
healthy or liver disease controls (HC1, HC2 and LC). A one-way ANOVA,
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with four groups (including healthy control group 2), indicated that no
two groups were significantly different on scores of anxiety at Time 2 (see
Table 5).
3.2.3. Depression
A repeated measures ANOVA, with 2 time points and 3 groups, indicated
that there was a significant overall difference in depression between the
groups (see Table 8). Examination of the means indicated that the healthy
control group was less depressed than both of the liver disease groups.
Table 8: Change in scores of depression.
Group Time 1 Time 2
Mean (SD) Mean (SD)
Liver
Transplant 5.2 (3.9) 3.5 (3.3)
Liver
Control 4.7 (5.0) 5.2 (4.4)
Healthy
Control 1 1.6 (1.7) 0.9 (1.8)
Group Effect F=4.65, p=0.016
Time Effect F=1.18, p=0.284
Interaction F=1.24, p=0.303
There was no overall change over time and there was no interaction
between the groups over time. Again, the largest change in scores over
time was the improvement in scores of the transplant group.
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Comparison of means at Time 2
All four groups were compared at Time 2 to assess whether depression
scores of transplant recipients (3 years post-transplant) were different to
those of healthy or liver disease controls. A one-way ANOVA, with four
groups (including healthy control group 2), indicated that there was a
significant overall difference in scores of depression between the groups
(see Table 5). A Scheffe test, p<0.05, however, indicated that no groups
differed significantly from each other.
3.2.4. Neuropsychological Measures
3.2.4.1. Memory - Rivermead Behavioural Memory Test
A repeated measures ANOVA, with two time points and three groups,
indicated that there was a significant overall difference in memory
between the groups (see Table 9). Examination of the means indicated that
the healthy control group scored higher than both of the liver disease
groups.
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Table 9: Change in scores of memory (RBMT).
Group Time 1 Time 2
Mean (SD) Mean (SD)
Liver
Transplant 16.7 (3.17) 20.4 (2.7)
Liver
Control 17.9 (3.6) 18.8 (3.7)
Healthy
Control 1 21.0 (1.4) 21.2 (1.9)
Group Effect F=5.79, p=0.007
Time Effect F=5.88, p=0.021
Interaction F=3.07, p=0.061
There was a significant overall improvement in scores over time, and an
interaction between the groups was verging on significance. To
investigate the change in scores over time, 2-tailed, related t-tests were
carried out for each group (see Table 10). These indicated that the memory
functioning of the transplant group had significantly improved at time 2
compared to time 1. No significant improvements were noted for the
liver disease control group and the healthy control group (see Figure 1).
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Table 10: t Values for within-group differences in memory scores.
SubjectGroup t value P







Figure 1: Change in memory function over time.
Time of Assessment
Comparison of means at Time 2
All four groups were compared at Time 2 to assess whether the memory
functioning of transplant recipients (3 years post-transplant) was different
to that of healthy or liver disease controls. A one-way ANOVA, with four
groups (including healthy control group 2), indicated that no two groups




A repeated measures ANOVA, with 2 time points and 3 groups, indicated
that there was a significant overall difference between the groups on digits
forwards (see Table 11). Examination of the means indicated that the
healthy control group performed better on this task than both of the liver
disease groups.
Table 11: Change in scores of digits forward.
Group Time 1 Time 2
Mean (SD) Mean (SD)
Liver
Transplant 7.3 (1.9) 8.0 (2.5)
Liver
Control 8.1 (2.03) 9.7 (3.3)
Healthy
Control 1 10.8 (1.7) 10.5 (1.7)
Group Effect F=6.38, p=0.005
Time Effect F=5.17, p=0.030
Interaction F=3.62, p=0.039
There was a significant overall effect of time and a significant interaction
between the groups. To determine the nature of this interaction, 2-tailed,
related t-tests were carried out for each group (see Table 12). These
indicated that the change in scores of digits forward of the liver disease
control group was verging on a significance. No significant
improvements were noted for the transplant group and the healthy
control group (see Figure 2).
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Table 12: t Values for within-group differences in digits forward scores.
SubjectGroup t value P







Figure 2: Change in scores of digits forward over time.
Comparison of means at Time 2
All four groups were compared at Time 2 to assess whether the
performance on digits forward of transplant recipients (3 years post-
transplant) was different to that of healthy or liver disease controls. A
one-way ANOVA, with four groups (including healthy control group 2),
indicated that there was a significant overall difference between the groups
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on digits forward performance (see Table 5). A Scheffe test, p<0.05,
however, indicated that no groups differed significantly from each other.
3.2.4.3. Digits Backward
A significant overall difference between groups was indicated by a repeated
measures ANOVA, with two time points and three groups. Examination
of the means indicated that the healthy control group performed better
than the liver disease groups at digits backward (see Table 13).
Table 13: Change in scores of digits backward.
Group Time 1 Time 2
Mean (SD) Mean (SD)
Liver
Transplant 4.8 (2.2) 6.7 (2.8)
Liver
Control 6.6 (2.0) 7.9 (3.0)
Healthy
Control 1 9.1 (2.1) 8.5 (2.5)
Group Effect F=5.02, p=0.013
Time Effect F=8.54, p=0.006
Interaction F=7.19, p=0.003
A significant overall effect of time, and a significant interaction between
the groups were found. To determine the nature of the interaction, 2-
tailed, related t-tests were carried out for each group (see Table 14). These
indicated that the transplant group showed a highly significant
improvement on digits backward at time 2 compared to time 1. No
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significant improvements were noted for the liver disease control group
and the healthy control group (see Figure 3).
Table 14: t Values for within-group differences in digits backward scores.
SubjectGroup t value Significance







Figure 3: Change in scores of digits backward over time.
Time of Assessment
Comparison of means at Time 2
All four groups were compared at Time 2 to assess whether the
performance on digits backwards of transplant recipients (3 years post-
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transplant) was different to that of healthy or liver disease controls. A
one-way ANOVA, with four groups (including healthy control group 2),
indicated that no two groups were significantly different on performance
on digits backward at Time 2 (see Table 5).
3.3. Analysis ofmeasures used at Time 2 only (DSST, VF, RSE, AOI,
SOS)
The second healthy control group ( healthy control group 2, matched to
the liver transplant group on age, years in education and estimated full
scale IQ, as well as sex, see Table 3) was included in these analyses.
3.3.1. Neuropsychological Measures
3.3.1.1. Verbal Fluency
A one-way ANOVA indicated that there was a significant overall
difference between the groups on the verbal fluency task (see Table 15). A
Scheffe test (with significance level p<0.05) was carried out to determine
the nature of this difference. This showed that both of the healthy control
groups performed significantly better than the liver disease groups. The
liver disease groups did not differ significantly from each other.
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fluency 33.1 (10.9) 31.2 (7.7) 49.5 (13.6) 47.3 (11.2) 7.97 0.0003
HC1, HC2
> Tr, LC




esteem 19.3 (6.6) 19.8 (8.1) 16.9 (4.2) 20.8 (4.0) 0.88 0.4584 -
Acc. of
illness 28.3 (8.7) 27.3 (8.7) - - 0.07 0.80 -
3.3.1.2. Digit Symbol Substitution Test
A one-way ANOVA indicated that there was a highly significant overall
difference between the groups on the DSST (see Table 15). A Scheffe test
(with significance level p<0.05) showed that both of the healthy control
groups performed significantly better than the liver disease groups. The
liver disease groups did not differ significantly from each other.
3.3.2. Acceptance of Illness
A one-way ANOVA indicated that there were no overall differences
between the liver disease groups on the Acceptance of Illness scale (see
Table 15). The scores for both groups (Tr and LC) fell within the range of
good acceptance of illness.
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3.3.3. Self-Esteem
A one-way ANOVA indicated that there were no overall differences
between the four groups on the RSE (see Table 15). All Four groups (Tr,
LC, HC1 and HC2) reported high self-esteem.
3.3.4. Social Support
One-way ANOVAs indicated that there were no differences between the
groups on any component of social support measured (see Table 16).










































0.3 (0.5) 0.8 (0.8) 0.5 (0.4) 0.6 (0.6) 1.37 0.266
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All groups (Tr, LC, HC1 and HC2) were receiving adequate emotional and
practical support.
In order to investigate the relationships between discrepancies in actual
and ideal levels of social support, and quality of life, anxiety and
depression, Pearson correlations were carried out (see Table 17). A
significant positive correlation between anxiety and discrepancy between
actual, and ideal, practical support was found. A positive correlation
between anxiety and discrepancy between actual, and ideal, emotional
support was verging on significance.
Table 17: Correlations between discrepancies in actual and ideal levels of
social support and QoL, anxiety and depression.




Psychological QoL -0.02 0.00
Physical QoL 0.18 .0.19
Anxiety 0.28 ** 0.30 *
Depression 0.22 0.18
*
= significant at p<0.05




As the present study included multiple variables, a summary of the results
will be presented to aid the reader's interpretation of the main findings of
the study.
4.1.1. Demographic Data
There were no differences between the four groups in distribution of sex
(Table 3). The liver disease groups (Tr & LC) and the second healthy
control group (HC2, assessed at time 2 only) were also well matched on
age, years in full time education and estimated full scale IQ. The repeated
measures healthy control group (HC1) was poorly matched to the
transplant group on these measures. Their inclusion in the study was to
control for repeated testing effects.
4.1.2. Quality of Life
The hypotheses indicated that there would be an interaction between the
three repeated measures groups (Tr, HC1 and LC) as follows: the
transplant group would show improved physical and psychological
components of QoL; the liver disease control group would show a
deterioration in physical and psychological QoL; and the healthy control
group would demonstrate no change in either of the components.
Significant overall between group differences in both physical and
psychological QoL indicated that the healthy control group (HC1) had a
better QoL than both of the liver disease groups (Tr and LC, Tables 4 and 6).
None of the groups changed significantly over time. The psychological
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and physical QoL of the liver transplant group did not differ significantly
from either the liver disease controls or the healthy controls post-
transplant. At the follow-up assessment time, the physical QoL of the
liver disease controls was significantly poorer than the healthy controls
(Table 5).
4.1.3. Anxiety and Depression
The hypotheses indicated that there would be an interaction between the
three repeated measures groups (Tr, HC1 and LC) as follows: the
transplant group would show improved anxiety and depression; the liver
disease control group would show a deterioration in anxiety and
depression; and the healthy control group would demonstrate no change
in either anxiety or depression.
Analysis of the results indicated that there were no overall differences in
anxiety between the groups (Tr, LC and HC1, Table 7). The healthy control
group (HC1) were significantly less depressed than the liver disease groups
(Tr and LC, Table 8). There were no significant changes in anxiety or
depression over time in any group.
4.1.4. Neuropsychological Measures
4.1.4.1. Rivermead Behavioural Memory Test
The hypotheses indicated that there would be an interaction between the
three repeated measures groups (Tr, HC1 and LC) as follows: the
transplant group would show improved memory; the liver disease
control group would show a deterioration in memory; and the healthy
control group would demonstrate no change in memory.
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Analysis of the results indicated that there was a significant overall
difference in memory between the groups (Tr, LC and HC1, Table 9). The
healthy control group demonstrated significantly better memory function
than the liver disease groups. There was a significant overall
improvement with time, and the interaction between the groups was
verging on significance. Further analysis indicated that the improvement
in memory function of the transplant group was highly significant,
whereas the slight improvements noted by both of the other groups were
not (Table 10).
In conclusion, the memory function of the transplant recipients improved
over time to the level of the healthy population.
4.1.4.2. Digits Forward
The hypotheses indicated that there would be an interaction between the
three repeated measures groups (Tr, HC1 and LC) as follows: the
transplant group would show improved performance; the liver disease
control group would show a deterioration in performance; and the
healthy control group would demonstrate no change in performance.
Analysis of the results indicated that there was an overall difference in
performance between the groups (Table 11). The healthy control group
(HC1) performed significantly better at this task than the liver disease
groups (Tr and LC). There was also a significant overall improvement in
performance over time. An interaction between the groups over time was
also significant, and further analysis indicated that the improvement in




The hypotheses indicated that there would be an interaction between the
three repeated measures groups (Tr, HC1 and LC) as follows: the
transplant group would show improved performance; the liver disease
control group would show a deterioration in performance; and the
healthy control group would demonstrate no change in performance.
Analysis of the results indicated that there was a significant overall
difference in performance between the groups (Table 13). The healthy
control group (HC1) performed better than the liver disease groups (Tr and
LC). There was a significant overall improvement with time, and an
interaction between the groups was also significant. Further analysis
indicated that the improvement in performance of the transplant group
was highly significant, whereas the slight improvement noted by the liver
disease control group, and slight deterioration of the healthy control group
(HC1) were not (Table 14).
4.1.4.4. Verbal Fluency
The hypotheses indicated that the liver transplant group (Tr) would
perform at the same level as the healthy control groups (HC1 and F1C2),
which would be better than the liver disease control group (LC).
A significant overall difference was found between the four groups (Table
15). Further analysis indicated that both of the healthy control groups
(HC1 and HC2) performed significantly better than both of the liver disease
groups (Tr and LC). There was no difference between the transplant group
and the liver disease control group.
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4.1.4.5. Digit Symbol Substitution Test
The hypotheses indicated that the liver transplant group (Tr) would
perform at the same level as the healthy control groups(HCl and HC2),
which would be better than the liver disease control group (LC).
A highly significant overall difference was found between the four groups
(Table 15). Further analysis indicated that both of the healthy control
groups (HC1 and HC2) performed significantly better than both of the liver
disease groups (Tr and LC). There was no difference between the
transplant group and the liver disease control group.
4.1.5. Acceptance of Illness Scale
The hypotheses stated that the liver transplant group (Tr) would have a
more positive acceptance of their illness than the liver disease control
group (LC).
No significant difference was found in acceptance of illness between the
two groups (Table 15).
4.1.6. Rosenberg Self Esteem Scale
The hypotheses stated that the liver transplant group (Tr) would have
equivalent self esteem levels to the healthy control groups (HC1 and HC2),
which would be higher than that of the liver disease control group (LC).




The hypotheses stated that discrepancies in social support would be higher
for both of the liver disease groups (Tr and LC), as their ideal levels of
support would be higher. It was also stated that discrepancies in
emotional or actual social support would be related to poorer QoL and
higher anxiety and depression.
No differences in actual, ideal or discrepancies between the two, in both
emotional and practical support, were found between the four groups (see
Table 16). Significant correlations indicated that the greater the
discrepancy between actual and ideal emotional and practical support, the
higher the anxiety reported (see Table 17). No significant correlations were
found between discrepancies and depression or QoL.
4.2. Selection Bias
It may have been the case that selection bias influenced the results. Of the
original 50 liver disease controls considered for repeat assessment, 28 had
died before the follow-up assessment and a further 11 failed to respond to
the request to take part in the follow-up assessment. It may have been that
those included in the follow-up liver disease control group were those
most well. This would have positively skewed the results. Indeed, all
those who took part were living independently at home. Nevertheless,
the same selection bias may have been true for the liver transplant group.
An overall selection bias in both liver disease groups stems from their
inclusion in the original assessment. This involved a selection bias given
that those who were too ill were not included as the assessment had to
take place up one flight of stairs, with no access to a lift.
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4.3. COMPARISONWITH OTHER STUDIES
There can only be a limited comparison to previous work as the present
study appears to be the first controlled study in this area that uses repeated
analyses of pre- and post-transplant data.
4.4. Support for each hypothesis (refer to section 1.13).
4.4.1. Liver transplant recipients will have improved on mood (anxiety
and depression), quality of life and neuropsychological measures.
Essentially, the most striking overall result from the present study is the
limited extent to which this hypothesis has been supported.
4.4.1.1. Quality of Life
The psychological and physical QoL of transplant recipients had not
improved significantly compared to pre-transplant levels (Tables 4 and 6).
Although there was no significant effect of time on the QoL of transplant
recipients, there were no significant differences in psychological QoL
between any of the groups (Tr, LC, HC1 and HC2) at Time 2 (Table 5). The
physical QoL of the transplant recipients did not differ significantly from
the healthy control groups or the liver disease control group at Time 2
(Table 5). There was, however, high variance in scores of both
psychological and physical QoL, and it remains to be seen whether
significant differences would be found with larger samples. With both
psychological and physical QoL components non-significant trends
towards improved QoL were found. With larger samples, it would be
hoped that the changes would be significant. The limitations of the
questionnaire used to assess QoL in the present study, the Rotterdam
Symptom Checklist, must be noted. At the initial recruitment time of the
study, the use of this measure was recommended by the Medical Research
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Council (McGuire & Selby, 1989). The measure is very easy to administer
and complete, which is crucial in longitudinal designs, which rely on
subjects agreeing to repeat assessments. It is, however, a fairly specific
measure, and the physical component used in the present study was
modified for use with liver disease patients. It may be that a more generic
item would have produced different results. Since that time other
measures have been developed, particularly the WHOQOL (WHOQOL
group, 1994), which was designed as an international, multidimensional,
generic instrument for use in health care. This measure would be the
measure of choice in future studies. Nevertheless, the present study
supports similar findings by Tarter et al. (1984), who reported no difference
in QoL between liver transplant recipients three years post-transplant and
a control group of Crohn's disease patients, using the Sickness Impact
Profile (SIP). Unfortunately, no healthy control group was included in the
study. Collis et al. (1995) reported improved levels of QoL (although no
repeated measures analysis was carried out), measured by the Nottingham
Health Profile (NHP), in a sample of 10 liver transplant recipients
(between 2 and 151 weeks post-transplant), although not to the levels of
the general population. No control group was included in the study, and
the variance in time between transplant and follow-up assessment was
large, thus limiting the interpretation of the results. It is clear that further
investigation of the QoL outcome of liver transplantation is needed. In
particular, prospective, well controlled studies using standardised
instruments with larger sample sizes are required.
4.4.1.2. Mood
Again, the intervention of liver transplantation did not significantly effect
the anxiety or depression levels of transplant recipients (Tables 7 and 8).
There were, however, no overall differences in anxiety levels between the
transplant group and the healthy controls or the liver disease control
group. In contrast other studies have found elevated anxiety levels of
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liver transplant recipients even years after transplantation (Kuchler et al.,
1991; Reither et al., 1992). Transplant recipients and liver disease controls
were, however, overall significantly more depressed than healthy controls
(HC1). In a retrospective study assessing the psychosomatic aspects of liver
transplantation, Surman et al. (1987) noted that 8/40 post-transplant
patients were referred for treatment for depressive symptoms. Further,
Sarin et al. (1988) found that a quarter of patients interviewed after
transplantation reported levels of anxiety or depression.
Collis et al. (1995) reported that there were no significant changes in levels
of anxiety and depression (measured by the General Health Questionnaire)
in a group of 11 transplant recipients, assessed pre- and between 2 and 151
weeks post-transplant. Unfortunately there were no control groups
included in the study for comparison. Cross-sectional analyses of mood
post-transplant have found elevated levels of anxiety and depression in
liver transplant recipients. Hicks et al. (1992), found that levels of
depressed and anxious mood were higher in patients greater than 2 years
post-transplant compared to a group less than 2 years post-transplant.
Tarter et al. (1984) assessed a group of 10 liver transplant recipients 3 years
post-transplant and found that they displayed moderate anxiety, somatic
distress and concern, frustration, depression, worry and social withdrawal,
compared to population norms. They found no difference between
transplant patients and a matched group of patients with Crohn's disease.
One explanation for the elevated anxiety and depression levels found in
transplant recipients in other studies is that the measures used to assess
mood were not designed for use with physically ill populations and
therefore the results reported in the study may be skewed. In the present
study, small sample sizes and high variability within groups may have
masked differences between groups, and changes over time that may have
been significant in a larger sample size. It is clear, again, that further
investigation of the impact that liver transplantation has on the levels of
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anxiety and depression of patients is required. Without pre-transplant
data and comparison to well matched controls, cross-sectional studies
measuring mood post-transplant provide little information. The only two
prospective studies in this area (the present study and Collis et al., 1995)
have found that liver transplantation has no effect on anxiety and
depression levels.
4.4.1.3. Memory
The significant improvements in memory (measured by the Rivermead
Behavioural Memory Test) of the liver transplant recipients following
transplantation was the most notable result of the present study (Tables 9
and 10). Within memory functioning categories of normal, poor,
moderate impairment and severe impairment specified by the RBMT, the
memory functioning of the liver transplant group at the pre-transplant
assessment stage fell within the level of moderate impairment on the
RBMT. At the post-transplant stage, transplant recipients were
performing within the level of poor memory functioning, although it
must be noted that the performance of both of the healthy control groups
was also within the level of poor memory functioning as categorised by
the RBMT. It may be that as samples vary, so do the boundaries between
the categories of memory functioning specified by the RBMT.
Nevertheless, the change in memory functioning of the liver transplant
group was clinically significant. Indeed, at the follow-up assessment there
were no significant differences between the liver transplant group and the
healthy control group (Table 5), indicating that at three years post-
transplant the memory function of transplant recipients is largely restored
to that of a group of matched healthy controls. This supports the findings
of improvement in memory functioning of 62 subjects following liver
transplantation by Tarter et al (1990a).
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The finding that liver transplantation was associated with a highly
significant improvement on the digits backward task is further evidence
that memory functioning of transplant recipients was improved post-
transplant (Table 13). There was no significant improvement by the
transplant group on the digits forward task (Tables 11 and 12), and there
was a significant overall difference in performance between the groups at
the post-transplant stage, although no groups differed significantly from
each other (Table 5). As well as a memory component, digits forward also
involves a large element of efficiency of attention. The lack of
improvement on the digits forward task of the transplant recipients
indicated that the significant improvement found on the RBMT cannot be
explained by improved attention post-transplant.
The impaired performance on digits forward and backward tasks (Tables 11
and 13), compared to the healthy control group (HC1), of both liver disease
groups (Tr and LC) in the present study was in contrast to results reported
by Tarter et al. (1990a), who found no impairments on digits forward or
digits backward in a liver transplant group either pre- or three years post-
transplant. Elsass et al. (1978), however, did find that a group of 22
cirrhotics were impaired on the digit span task. Variability within samples
may explain these differing results, and therefore the use of the digit span
subtests in cross-sectional analyses may not be recommended. The use of
the digit span subtests in repeated measures analysis in the present study,
however, has provided important evidence of improvements in memory
functioning, regardless of attention, 3 years post-transplant.
The significant improvements in memory after liver transplantation
found in the present study are particularly important. Individual goals
often include returning to work and resuming activities which had not
been possible for some time as their liver disease deteriorated prior to the
transplant. Memory function can be a vital component to many jobs and
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activities. Further, adherence to the strict anti-rejection medication
regimens required a good working memory.
4.4.1.4. Executive function and psychomotor speed
In the cross-sectional analysis at Time 2, executive function of transplant
recipients, as measured by verbal fluency, was significantly poorer to that
of the healthy control groups (HC1 and HC2, Table 15). There was no
difference in performance on the verbal fluency task between the liver
transplant group and the liver disease control group. Impairment on
verbal fluency in a group of 22 cirrhotics was also found by Elsass et al.
(1978). The same pattern of results was found for performance on the digit
symbol substitution test (Table 15), which measures psychomotor speed
and is particularly sensitive to the cognitive impairment associated with
liver disease (O'Carroll et al., 1991, Gitlin et al., 1986). The findings that
there were no differences between the two liver disease groups on these
tasks (VF and DSST) is important, and suggests that the functions being
measures by these tasks are less reversible than other neuropsychological
impairments associated with chronic liver disease. It may be that these
functions take longer to return post-transplant than memory and
attention. Alternatively, it may be that these impairments in the
transplant recipients reflect permanent cerebral damage. Interestingly, the
finding that impairment on the DSST task endures following a liver
transplant was also found by Tarter et al. (1990a). In a larger sample
(N=62), the DSST was one of only four out of 26 tasks remaining impaired
three years post-transplant, although no repeated measures analysis was
included in the study to assess whether there had been any change over
time. Finally, it may be that the neuropsychological functions measured
by these tasks are impaired by the medication that the liver transplant
recipients are taking. Motor tremor, for example, has been noted to be a
side-effect of immunosuppressant medication (Tarter et al., 1990a). The
DSST task tests psychomotor speed, and therefore may be particular
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sensitive to these effects. The lack of pre-transplant data on these tasks in
the present study must be acknowledged, and limits the interpretation of
the results given that data on any improvements or deterioration in
functioning are lacking.
4.4.2. The liver disease control group will have deteriorated on mood,
quality of life and neuropsychological measures.
Another striking result of the present study is the minimal support for
this hypothesis, and indeed in many cases the improved functioning
found in this group after an interval of three years. As expected, the liver
disease control group had significantly poorer overall physical and
psychological quality of life than healthy controls (HC1), but no change
had occurred over time (Tables 4 and 6). There were no differences in
anxiety levels between the groups (Tr, LC and HC1), and again anxiety
levels of the liver disease control group did not change over time (Table
7). Overall, the liver disease control group were significantly more
depressed than healthy controls (HC1), and although there was an overall
significant difference between the groups at Time 2, no groups differed
significantly from each other (Table 5). Again, there was no change in
levels of depression in the liver disease controls over time (Table 8).
Importantly, there was no deterioration on any measure of
neuropsychological functioning of the liver disease control group over
time (Tables 9-14). In fact, the performance of the liver disease control
group on the digits forward task improved over time to a level verging on
significance (Table 10).
In summary, the only measure which differentiated the liver disease
controls from the liver transplant recipients at Time 2 was the physical
component of QoL (Table 5).
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4.4.3. The healthy control group (1) will show no change on mood,
quality of life and neuropsychological measures.
This hypothesis was supported on all the measures included in the
present study. The time between the assessments was lengthy, and where
possible, parallel versions of tests were used, thus minimising an effect of
repeat testing. Although the repeated measures control was poorly
matched to the liver disease groups, its inclusion was useful by allowing
the elimination of repeat testing affects. Further, healthy control group 1
did not differ from healthy control group 2 (well-matched to the liver
disease group) on any measure included in the present study.
4.4.4. Self-esteem of liver transplant recipients will match that of
healthy controls, whereas liver disease controls will have lowered self-
esteem.
A clearly unexpected finding was that there were no differences between
the four groups (Tr, LC, HC1 and HC2) in self-esteem, with all groups
reporting high self-esteem (Table 15). The measure used to assess self-
esteem is one commonly used in health psychology, therefore designed to
target components of self-esteem that can be affected by health problems.
Wolcott et al. (1989), using a different measure, Simmons Scale of self-
esteem, also reported high self-esteem in a group of 41 liver transplant
recipients. What is also notable is that the mean levels of self-esteem
found in the present study samples are very different to those reported in
a normal population sample of 2,294 North American men and women
between the ages of 18 and 65 using the Rosenberg Self-Esteem Scale
(mean=34.7 (sd=4.9), Rosenberg, 1989). Low scores indicate high self-
esteem, with the scores ranging from 10 to 40. The mean levels of self-
esteem reported in the present study are much higher: liver transplant
group, 19.3 (sd=6.6); liver control group, 19.8(sd=8.1); healthy control group
1,16.9(sd=4.2); and healthy control group 2, 20.8(sd=4.0). The present
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groups all demonstrate high self-esteem compared to the published
norms. The reasons for these discrepancies are unclear, but perhaps reflect
differences between North American and Scottish samples.
4.4.5. Transplant recipients will have a more positive acceptance of
illness than chronically ill liver disease controls.
No difference between the two liver disease groups (Tr and LC) was found
in their acceptance of illness scores (Table 15). Both groups' scores showed
good acceptance of their illness, and were equivalent to published means
with another chronic illness sample (Felton & Revenson, 1984). Although
the transplant group could be considered no longer to be suffering from an
illness (and indeed one subject did not fill in the questionnaire for this
reason), many still report high levels of physical symptomatology
(physical component of QoL scale), and all are taking high levels of
medication, without which they would become very ill. It was predicted
that the transplant group, given their successful transplant status, and the
associated expected resumption of roles and activities, would have
reported a better acceptance of illness. The fact that this was not the case
indicates that there is not a shift in acceptance of the limitations of their
health as expected.
4.4.6. Inadequate perceived social supportwill be associated with
poorer quality of life and higher levels of anxiety and depression.
Again, no differences between the four groups (Tr, LC, HC1 and HC2) were
found in actual or ideal, emotional and practical social support (Table 16).
All groups were satisfied with the levels of emotional and practical social
support they received. The high level of social support noted by
transplant recipients in the present study supports findings by Leyendecker
et al. (1993), who found that 80% of their sample of 45 liver transplant
recipients reported having good social support. Another study found that
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almost all of their sample of transplant recipients reported that family
support was the most important factor in helping to cope with the post¬
transplantation period (Kuchler et al., 1991). The selection bias described
in section 4.2. may in part explain the high levels of social support noted
by both liver disease groups in the present study. The relationship
between social support and health is unknown, and it may be that poor
social support is related to higher levels of post-operative complications.
Certainly, the adjustment to post-transplant changes, in particular the
strict immunosuppressant medication regimens, would be difficult
without good support from those around the individual. Many transplant
recipients in the present sample reported the need for reminders and
routines in their lives to help them cope with the pressure of drug
regimens, frequent hospital appointments and constant fears of rejection
and infections. Family and friends played an important role in facilitating
these routines, and keeping the motivation going to keep to them. In
contrast, another study found that, in an effort to maintain some control,
the liver transplant recipients included in their study put themselves at
risk by adjusting the times of their immunosuppressant medication
(Thomas, 1993).
Across all groups in the present study, there were significant positive
correlations between anxiety and discrepancy between actual and ideal,
emotional and practical social support (Table 17). In other words, when
actual emotional or practical support did not match up to ideals levels, the
greater the anxiety reported. No significant correlations were found
between social support and depression or QoL. The measure used to assess
depression, the Hospital Anxiety and Depression Scale, is a fairly narrow
measure of depression, and tends to focus on the symptom of anhedonia
(Moorey et al., 1991). It may be that a more general measure of depression
would be more likely to correlate with social support.
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A study of supportive behaviours and sources of supportive behaviours in
20 pre-transplant adult patients with chronic liver disease, Geary et al.
(1994) found that family was mentioned most as a social support. The
types of supportive behaviour reported by patients included visits,
telephone calls, prayers, cards, encouragement and chatting. A prospective
study of these patients post-transplant, to investigate the role of social
support further would be interesting. Wolcott et al. (1989) highlighted the
discrepancy between large social networks but little social interaction
experienced by their sample of liver transplant recipients. Their sample
included a heterogeneous group of patients between 4 and 36 months post-
transplant. It could be hypothesised that this discrepancy was more
problematic the longer the time since transplantation, as health improves
and recipients strive to regain social roles.
The importance of encouragement and support from family and friends
was stressed by eight liver transplant recipients interviewed for a
qualitative study designed to investigate the experience of liver
transplantation (Wainwright, 1995). These recipients noted that social
support was particularly important in the months following discharge
from hospital, when the feelings of safety and security of being on the
ward, with many nurses on hand, is lost. Further, the recovery process
once at home can be slow, and physical limitations can remain for some
time.
There is some evidence that support from fellow patients, either formally
through support groups, or informally through friendships made while
on the ward, can be very beneficial (Taylor, 1991; Moos & Schaefer, 1986).
In fact, many patients report that they receive more information about the
recovery trajectory of transplantation from other patients rather than from
health professionals (Wainwright, 1995). Indeed the process of receiving
support from other transplant recipients can follow a pattern in which
each individual progresses to the role of supporting others, thus
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reciprocating the support they had initially received. By three years post¬
operatively, however, the extent to which contact with other transplant
recipients is beneficial is unclear. As time goes on, some transplant
recipients report that they want to forget about their experiences of the
transplant procedure and any difficulties they may have faced in the early
stages after the transplant. It may be that the need for continued support
from other transplant recipients reaches an end.
4.5. QualitativeData: Problems Faced byTransplant Recipients
4.5.1. Waiting for the Transplant
The decision-making process that the transplant candidate goes through in
deciding whether or not to have a transplant is complex. Some people
cope better with a degree of choice and freedom, and others find this very
stressful. The assessment procedure is lengthy and invasive, requiring
transplant candidates to spend up to a week in hospital away from their
homes. Liver transplant centres are regional, and there is only one in
Scotland, based at the Royal Infirmary of Edinburgh. Patients from all
over Scotland come to Edinburgh for assessment and, if considered
suitable and if they agree, the transplantation procedure itself. Once it has
been decided by all parties concerned that an individual should be placed
on the waiting list for a liver transplant, they are sent home with a bleeper
to wait for a suitable donor to become available. Up until the time the
bleeper goes off, and the transplantation procedure is commenced, most
transplant candidates have not considered fully the real impact that the
transplant will have on their lives. Transplant recipients generally
describe relief when the bleeper goes off, and it can be an emotional time
as the prospect of death becomes imminent, when the individual says
goodbye to family and friends (Wainwright, 1995).
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4.5.2. Post-Transplant Adjustment
It was noted by a number of liver transplant recipients interviewed for this
study that they were not prepared for the problems they experienced,
particularly in the first year after their transplant. The initial euphoria,
experienced when the realisation that the patient has survived the
operation, can be short lived (Wainwright, 1995). Many of the transplant
recipients described that they felt forgotten about by the transplant team
once they had gone home after the transplant. Further, they find it very
difficult to communicate fears and worries to the medical team. This is
vital when it is considered that most transplant units do not routinely
involve a psychologist, or other professional, who keeps in touch with the
patients once they have been discharged. The only people that the patients
see regularly are members of the medical team during out-patient
appointments. Another factor that prevents patients acknowledging any
fears, is that many of them have met and befriended other transplant
candidates or recipients who have since been very ill and perhaps died
during the transplant procedure or post-operatively. This can make the
individual feel even more guilty about expressing difficulties, and can also
highlight uncertainty about their own future.
The stresses and fears experienced post-operatively, once an individual
has returned home, can be severe. Fear of rejection and infection can be
intense, and many recipients report excessive symptom checking. Any
infection the recipient picks up could jeopardise the health of their new
livers, and therefore avoidance of places where infections may be picked
up is understandable. This can be particularly difficult for parents of
young children. In contrast, another study found that, in an effort to
maintain some control, the liver transplant recipients they interviewed
put themselves at risk by adjusting the times of their immunosuppressant
medication and exposing themselves to situations that could increase
their risk of infection (Thomas, 1993). This perhaps highlights the very
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different experiences of liver transplantation faced by individual
recipients. Anxiety symptoms can mimic more serious physical problems,
for example racing heart, sweating, dry mouth, stomach churning and
headaches. It could be concluded that this population of patients may
benefit from the opportunity of access to psychological services, at the least
to provide training in anxiety management techniques. The present
sample did not show elevated levels of anxiety. Nevertheless, other
researchers have noted that anxiety tends to peak in transplant recipients
at times of crisis, for example during an infection (Kuchler et al., 1991).
Further, the present sample were interviewed three years after their
transplant, and most reported that by this stage they were coping much
better, and with time the intensity of the fear of rejection and infection
fades. It seems that the time when recipients are in most need of
professional support is in the first year post-transplant. Indeed, Lowe et al.
(1990) found that patients have more problems in the first year after a
transplant that in the second or subsequent years. Survival through the
first year post-transplant is seen as a significant hurdle both by patients and
the medical team (Iwatsuki et al., 1987).
A major issue in the evaluation of the quality of life of transplant
recipients is that individual differences must be considered. For example,
a retired man, who has completed his working life and raised his family
will have very different needs to a younger man who, prior to the
development of chronic liver disease, had a manual job and was raising
young children. The second man may need more input and advice from
individuals to facilitate not just returning to work, but changing his
profession. Many transplant recipients can be penalised by the
employment services after receiving a successful transplant, as they are no
longer considered "ill". A lack of understanding of the difficulties they
face can be very upsetting and isolating. Levy et al. (1995) noted that some
of their sample of liver transplant recipients had problems finding work
or health insurance coverage (a particular problem in North American
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samples), despite being healthy. The lack of advice on Social Security
benefits, life assurance and job prospects was also highlighted as a major
concern by the sample of liver transplant recipients interviewed by
Wainwright (1995). A service providing advice, and liaising with other
services, based in the transplant unit where these difficulties can be fully
understood, should be available to transplant recipients.
The physical and psychological difficulties associated with chronic liver
disease can result in the loss of roles, for example being able to care for
your family, or being the main wage earner in the family. The reclaiming
of these roles is an important aspect of an individuals' recovery from liver
transplantation, as it provides individuals with a strong indication of
improvement in their health. Failure to resume roles can be seen as
evidence that illness is persisting (Johnson, 1991). Reclaiming former
roles can, however, be difficult. Support from family and friends, which
can be vital in the early stages post-operatively, can be perceived as over
protection as the individual attempts to regain roles. In a group of women
recovering from hysterectomy, it was found that family roles were harder
to reclaim than roles at work and in the community (Chasse, 1991).
Although liver transplant recipients may experience greater difficulties
returning to work and reintegrating into the community than
hysterectomy patients due to the nature of the surgery and the greater risk
of complications, it may be that reintegration into family roles can be as
difficult.
Despite the significant improvements in memory functioning of liver
transplant recipients shown in the present study, it must be noted that a
number of patients reported subjective complaints of memory problems.
It may be that as health improves and roles are reclaimed, memory lapses
become more noticeable. The old maxim, " use it or loose it", may be
relevant here. Alternatively, it may be possible that transplant recipients
are mislabelling 'normal' memory lapses as organic impairment
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following the transplantation procedure. Similar findings were reported
by Commander et al. (1992), who found that 40.6% of their sample of liver
transplant recipients reported subjective memory problems.
4.6. Strengths of the Present Study
The present study has provided valuable information about the
psychological sequelae of a relatively new health intervention. The
prospective design, including three control groups and a holistic approach
using standardised measures is in sharp contrast to the poorly designed
majority of previous studies investigating neuropsychological and quality
of life outcomes of liver transplantation. Results from the present study
can therefore shed a realistic light on the experience and functioning of
liver transplant recipients. Further, the present study attempted to
overcome the risk of transplant recipients 'faking good' as it was carried
out independently of the clinical contact with the transplant team, with
the follow-up interview carried out at the patient's home when possible.
In this way it was hoped that the liver transplant recipients included in
the study would feel able to indicate any difficulties they were
experiencing without guilt due to feelings of gratitude to the transplant
team.
4.7. Weaknesses of the Present Study
Although the most obvious criticism is the inclusion of small sample
sizes, it must be noted that the present study was carried out within strict
time constraints, which limited the time available for the very lengthy
process of follow-up assessment recruitment. This point is particularly
relevant to transplant research given that most transplant centres are
centralised, and patients attending the service can come from a wide
geographical area. By three years post-transplant, most transplant
recipients only visit the transplant unit at the Royal Infirmary of
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Edinburgh once a year. For this study most follow-up assessments,
therefore, needed to be carried out during home visits, which involved a
great deal of travelling by the researcher.
It would be unethical to use a randomised, controlled trial design to
investigate the psychological sequelae of liver transplantation. A chronic
liver disease control group was included in the present study for
comparison. The liver disease control group did not differ from the
transplant group in terms of severity of liver disease at the initial
recruitment stage or proportion of alcoholic cirrhotics included (Table 2)
although the effects of immunosuppressant medication could not be
controlled for (Reither et al., 1992).
The transplant recipients in the present study were limited to those who
received their transplant due to chronic liver disease. A population of
liver transplant recipients who received their transplant due to acute
hepatic failure remain under-researched.
4.8. Factors thatMediate Successful Adjustment to
Transplantation
Psychosocial adjustment to a prolonged life-threatening illness and major
surgery, like liver transplantation, is shaped by numerous factors (Tarter et
al., 1988c). The success of the transplantation procedure itself is one of
these factors. This in turn is mediated by a number of variables. The
chronicity of the underlying liver disease, the type of liver disease,
concurrent illnesses, age, gender and grafting of the donor liver are all
variables that will influence the success of the transplantation. Foley et al.
(1989) found no correlation, however, between symptom frequency and
associated distress and quality of life. Similarly, Leyendecker et al. (1993)
found no relationship between low quality of life and transplant
malfunction. Tarter et al. (1987b), however, found that psychosocial
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adjustment to transplant was poorer for multiple transplant recipients
rather than single transplant recipients. Only two out of the sixteen liver
transplant recipients included in the present study had required a second
liver transplant due to rejection of the first. Nevertheless, the variable of
post-transplant complications was not included in the present study, and
therefore remains a factor that requires further investigation.
4.9. WHAT THE PRESENT FINDINGS TELL US ABOUT LIVER TRANSPLANTATION
The present study provides rather different findings with regard to the
psychological outcome of liver transplantation than those involved in the
Scottish Liver Transplant Unit would have expected. In particular it was
expected that quality of life would improve, and levels of anxiety and
depression would decrease, in this group of transplant recipients 3 years
post-transplant. Certainly, a literature review on the subject would lead
the reader to believe that improvements in QoL are to be expected. Close
inspection of the literature on this subject, however, reveals that it is rife
with methodological flaws. Further, it may be that there is a selection bias
in the type of study presented for publication given the pressure on
transplant units to publish positive results. The present study is the first
prospective, controlled study of its kind, evaluating neuropsychological
functions, QoL and mood with standardised instruments 3 years post-
transplant. Although small sample sizes limit the conclusions that can be
drawn from the present study, it provides rather sobering evidence that
the perceived benefits of liver transplantation in terms of QoL and mood
are unrealistic. Nevertheless, there is clear evidence that mortality is
reduced by the intervention of liver transplantation. That is, although
QoL and mood did not improve 3 years post-transplant, the chance of
death was significantly decreased (see section 3.1).
The conclusions that can be drawn from this evidence are perhaps most
important in relation to the justification for transplantation. The
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decision-making process involved in the assessment procedure can
involve trade-offs between survival and QoL. A sample of those who
receive a liver transplantation do so for purely QoL issues, before it is
deemed a medical necessity. Patients may decide to have a liver transplant
with the expectation that it will improve their QoL. The evidence
provided in the present study perhaps casts doubt on whether liver
transplants should be carried out for this reason. Despite survival benefits
associated with transplantation, a transplant carried out before it is a
medical necessity involves a degree of risk of premature death, whether
on the operating table or due to post-operative complications. Further, if
expectations about an improved QoL are not met, adjustment to living
with a liver transplantation may be very difficult. Pre-operative
counselling of patients assessed for liver transplantation, based on the
empirical evidence of the present study, would have to highlight that QoL
may not improve after the transplant and many difficulties may be faced.
It remains to be seem whether this would influence the decision-making
process of either the patient or the surgeons and physicians. It is
interesting to note that there is now a body of literature recommending
that QoL should be an important factor in the decision making process
involved in the treatment of cancer (e.g. Reifel & Ganz, 1997). QoL has
also been demonstrated to be a predictor of patient prognosis and response
to treatment for metastatic lung cancer (Ganz et al., 1991). It may be that
successful treatment of cancer can restore an individuals' QoL entirely in
the sense that the individual can be completely 'cured'. Liver transplant
recipients, on the other hand, may not feel 'cured' as they remain on a
lifetime of immunosuppressant medication and carry with them the fear
of rejection and infection. Further, transplant recipients' sense of
themselves may be distorted by knowing that they have a new organ in
their body. The support for this latter point is mixed and requires further
investigation (Wainwright, 1995).
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The significant improvements in memory functioning found in the
present study, however, provide empirical evidence of the
neuropsychological benefits of liver transplantation. The measure used in
the present study to assess memory function (RBMT) was chosen because
it was designed to detect impairment of everyday memory functioning
and to monitor change over time. The items involve either remembering
to carry out some everyday task, or retaining the type of information
needed for adequate everyday functioning. It can therefore be concluded
that the significant improvement on this measure would have a
meaningful impact on the individuals' functioning in normal life.
Further, there was no difference between scores on the RBMT between
transplant recipients and well matched controls 3 years post-transplant,
indicating that the intervention of liver transplantation normalises the
memory functioning of recipients. Despite this, however, recipients in the
present study were still complaining of memory problems. It may be that
they need reassurance and reminding that a degree of memory lapses are
normal experiences.
4.10. Conclusions
The present study is the first prospective, controlled study of QoL, mood
and neuropsychological functioning in a sample of Scottish liver
transplant recipients. The most striking results of the present study are
the lack of improvements in the quality of life and mood of transplant
recipients three years post-transplant, compared with pre-transplant
levels. There was, however, a significant and meaningful improvement
in the memory functioning of transplant recipients. Concerns over the
rising cost of healthcare, and the need to justify expensive interventions
such as liver transplantation, have focussed attention on psychological
outcome measures. Nevertheless, the present study provides some
evidence that the psychological needs of liver transplant recipients are not
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always met. This has implications for the development of clinical
psychology services as well as management of liver transplant units.
4.11. Future Research
Research in this area has tended to be characterised by methodological
flaws. Evidently there is a need for more prospective, controlled studies,
with larger sample sizes investigating the psychological sequelae of liver
transplantation. More specifically, a number of research questions remain
to be investigated, for example:
1. Does psychological outcome of liver transplantation for acute liver
failure differ from that for chronic liver failure?
2. Do interventions aimed at aiding adjustment to transplantation, e.g.
support groups and anxiety management, improve quality of life and
mood in transplant recipients?
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Royal Infirmary of Edinburgh
Dear
You may recall that we met previously when you were having treatment for liver disease
at the Royal Infirmary of Edinburgh. I am currently contacting all those people with
whom I had contact at that time. This is part of an evaluation of the longer term impact
of liver disease and its' treatment.
I have included a number of questionnaires for you to complete, some of which you will
have completed previously. A postage paid return envelope is also enclosed. However, I
am also keen to meet with as many people face to face to discuss how you are getting on.
This would either take place at the Royal Infirmary of Edinburgh at your own home,
whichever is most convenient for you. I have enclosed a form for you to fill out
indicating whether you would be prepared to meet with me or not. I would be very
grateful if you could return this to me.
Please do not hesitate to contact me if you
regarding this work.
I look forward to hearing from you.
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Dear Rebecca Gooday
Further to your letter I would like:
No further contact
Please tick as appropriate.
To meet with you at the
Royal Infirmary of Edinburgh
To meet with you at my home
My telephone number is
Signed
Appendix 3: Rotterdam Symptom Checklist
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ROTTERDAMSYMPTOM CHECKLIST (CORE)
Patient's Name: Date of Assessment:
Transplant Status: Other:
In this questionnaire you will be asked about your symptoms. Against each item place a firm tick
under the heading that best describes how you have been feeling during the past week.
Not at all A little Moderately Very much



















19. Tingling of hands or feet
20. Difficulty concentrating
21. Concern about jaundice
22. Itching
23. Lack of energy




Appendix 4: Hospital Anxiety and Depression Scale
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1:1AO_S£AL£ Dale ID No.
Read each item and place a lick in the box opposite tine reply which comes closest
to how you have been feeling in the past week.
Don't take too long over your replies: your immediate reaction to each item will
probably be more accurate than a long thought-out response.
feel tense or 'wound up':
Most of the time
A lot of the time
Time to time. Occasionally
Not at all
still enjoy the things I used to enjoy:
Definitely as much
Not quite so much
Only a little
Hardly at ail
set a sort of frightened feeling as if
amething awful is about to happen:
Very definitely and quite badly
Yes, but not too badly
A little, but it doesn't worry me
Not at all
:an laugh and see the funny side of
ings:
As much as I always could
Net quite so much r.cv/
Definitely net so much now
Net at at!
orrying thoughts go through my
nd:
A great deal cf the time
A let of the time






vtost of the time





feel as if I am slowed down:




I get a sort of frightened feeling like





have lost interest in my appearance:
Definitely
I don't take so much care as I should..
I may not take quite as much care
I take just as much care as ever







lock forward with enjoyment to things:
As much as ever I c'id
Rather less than I used to
Definitely less than I used to
Hardly at ail



















Here is a list of statements dealing with your general feelings about yourself. If you agree
with the statement, circle A. If you strongly agree, circle SA. If you disagree, circle D. If you











1. On the whole, I am satisfied with myself. SA A D SD
2. At times I think I am no good at all. SA A D SD
3. I feel that I have a number of good qualities. SA A D SD
4. I am able to do things as well as most other
people. SA A D SD
5. I feel I do not have much to be proud of. SA A D SD
6. I certainly feel useless at times. SA A D SD
7. I feel that I'm a person of worth, at least on an
equal plane with others. SA A D SD
8. I wish I could have more respect for myself. SA A D SD
9. All in all, I am inclined to feel that I am a
failure. SA A D SD
10. I take a positive attitude toward myself. SA A D SD
© Rosenberg, 1965. From Society and the Adolescent Self-Image. Princeton: Princeton University Press. Reproduced
with the kind permission of the author.
This measure is part of Measures In Health Psychology: A User's Portfolio, written and compiled by Professor Marie
Johnston, Dr Stephen Wright and Professor John Weinman. Once the invoice has been paid, it may be photocopied for
use within the purchasing institution only. Published by The NFER-NELSON Publishing Company Ltd, Darville
House. 2 Oxford Road East, Windsor. Berkshire SL4 1DF, UK. Code 4920 09 4
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Please respond to each of the following items by choosing a number from 1 to 5 on the scale
adjacent to the item which you feel best describes you. Then circle the number you have
chosen. There are no right answers to any of the questions.
1. I have a hard time adjusting to the limitations of my illness.




2. Because of my health, 1 miss the things 1 like to do most.




3. My illness makes me feel useless at times.




4. Health problems make me more dependent on others than 1 want to be.




5. My illness makes me a burden on my family and friends.




6. My health does not make me feel inadequate.




7. 1 will never be self-sufficient enough to make me happy.




8. I think people are often uncomfortable being around me because of my
illness.




© Felton. 1984. Reproduced with the kind permission of the author.
This measure is part of Measures in Health Psychology: A User's Portfolio, written and compiled by Professor John
Weinman. Dr Stephen Wright and Professor Marie Johnston. Once the invoice has been paid, it may be photocopied
for use within the purchasing institution only. Published by The NFER-NELSON Publishing Company Ltd, Darville
House, 2 Oxford Road East, Windsor, Berkshire SL4 1DF, UK. Code 4920 06 4
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Appendix 7: Significant Others Scale
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SIGNIFICANT OTHERS SCALE ™
(B)
Instructions
Please list below up to seven people who may be important in the individual's life. Typical
relationships include partner, mother, father, child, sibling, close friends, plus keyworker. For
each person please circle a number from 1 to 7 to show how well he or she provides the type
of help that is listed.
The second part of each question asks you to rate how individuals would like things to be if
they were exactly as they hoped for. As before, please put a circle around one number
between 1 and 7 to show what the rating is.
Person 1 - Never Sometimes Always
a) Can you trust, talk to frankly and share your feelings with this
person?
b) What rating would your ideal be?
a) Can you lean on and turn to this person in times of difficulty?..
b) What rating would your ideal be?
a) Does he/she give you practical heip?
b) What rating would your ideal be?
a) Can you spend time with him/her socially?.
b) What rating would your ideal be?
2 3 4 5 6 7
2 3 4 5 6 7
2 3 4 5 6 7
2 3 4 5 6 7
2 3 4 5 6 7
2 3 4 5 6 7
2 3 4 5 6 7
2 3 4 5 6 7
Person 2 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of difficulty?.. 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 3 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of difficulty? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7




■ Never Sometimes Always
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of
difficulty? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially? .... 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 5 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of
difficulty? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially? .... 1 2 o 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 6 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of
difficulty? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 7 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 b b 7
2 a) Can you lean on and turn to this person in times of
difficulty? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 b 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 b 7
4 a) Can you spend time with him/her socially? .... 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 b 7
PLEASE CIRCLE ONE NUMBER ONLY FOR EACH QUESTION
© Power and Champion, 1988. From 'The development of a measure of social support: The Significant Others (SOS)
Scale', British Journal of Clinical Psychology, 27, 349-58. Reproduced with the kind permission of the authors.
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